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1.1 Glutamate decarboxylase-dependent acid resistance in 
orally-acquired bacteria 
1.1.1 Acid resistance in orally-acquired bacteria 
Acid stress is one of the most hostile conditions for the bacterial cell. 
Generally, even small changes in the intracellular pH (pHi) have drastic 
effects on cell growth and this is why most bacteria are able to maintain a 
fairly constant internal pH when grown in a wide range of media at different 
external pH (pHo) (Slonczewski et al., 2009, Krulwich et al., 2011).  The pHi 
of Escherichia coli for example changes only from 7.2 to 7.8 over a pHo 
range of 5.5 to 9 (Slonczewski et al., 1981). The outcome is that the pHi is 
always kept higher respect to an acidic pHo and lower with respect to an 
alkaline pHo. Thus fluctuations in pHi are clearly undesirable, as confirmed 
by the fact that bacteria are limited, for example, in the range of acidic pH 
values at which they are able to grow and show a transcriptional and 
translational response to a drop in pH. In fact, most of the biological 
molecules carry out their functions only in a limited range of pH. 
This assumptions are particularly important for neutrophilic orally-
acquired bacteria which, in order to colonize the mammalian host 
gastrointestinal tract (GIT), must survive a > 2-hour exposure to the 
extremely acid secretions (pH < 2.5) of the stomach, the major bactericidal 
barrier of the GIT (Giannella et al., 1972). Additional acid stress  occurs in 
the distal gut, where the short chain fatty acids (SCFAs) such as acetic, 
propionic, butyric and lactic acid are produced by the resident microbiota via 
anaerobic fermentation (Flint et al., 2008). In fact, SCFAs are able to cross 
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the cell membrane in the undissociated form and then, once in the cytoplasm, 
dissociate, thereby causing internal pH acidification. 
Therefore the ability to perceive and cope with acid stress is crucial for 
successful colonization of the GIT and to survive in other acidic 
environments (i.e. fermented food). 
In enteric pathogens, acid resistance (AR) is considered a virulence trait. 
In fact the infectious dose (ID) of different enteric pathogens is directly 
proportional to their relative ability to withstand acid. Acid-sensitive 
pathogens, like Vibrio cholerae (ID50 = 1x10
9
), overcome the stomach barrier 
only by a massive entry, which allows few cells to survive and reach the gut. 
On the contrary, acid-resistant enterobacteria such as E. coli and Shigella 
flexneri (ID50 = 1x10
2
) possess a combination of various molecular 
mechanisms which collectively work by counteracting the entry of protons, 
mostly by consuming and pumping out them in order to prevent damage of 
macromolecules. 
Bacterial acid survival systems are typically classified either as ATR (acid 
tolerance response) or as AR (acid resistance). The two systems differ in that 
the ATR (log- or stationary-phase) requires pre-exposure of the bacteria to a 
mildly acidic pH before the acid challenge at pH  3.0, whereas AR typically 
protects from an extreme acid stress (pH  2.5) stationary-phase cells which 
were not pre-adapted (Foster, 2001, Merrell & Camilli, 2002). 
In E. coli the acid stress response (reviewed by (Kanjee & Houry, 2013)), 
consists of (i) passive mechanisms, owing to the buffering capacity of amino 
acids, proteins, polyamines, polyphosphate, and inorganic phosphate present 
in the cytoplasm; (ii) physiological adaptations, such as membrane 
modifications (i.e. content of fatty acids and outer membrane porins to reduce 
proton influx) and acid pH-triggered activity of periplasmic chaperones; (iii) 
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metabolic responses, such as those occurring during aerobic growth under 
mild acid stress, that support proton efflux via the components of the electron 
transport chain; (iv) proton-consuming and ammonia-producing reactions 
that rely on the activation of acid-inducible amino acid-dependent 
decarboxylases and deaminases (Kanjee & Houry, 2013, Lu et al., 2013). In 
the latter case five acid resistance (AR) systems have been characterized, and 
each has two components: a cytoplasmic pyridoxal 5’-phosphate (PLP)-
dependent decarboxylase or a deaminase (in one case), that catalyses the 
reaction on the relevant  amino acid, and an inner membrane antiporter which 
exchanges the incoming substrate for the exported product of the reaction 
(Foster, 2004, Lu et al., 2013).  
In addition to the amino acid-dependent AR systems which are typically, 
though not exclusively, induced under fermentative conditions, E. coli 
possesses also an oxidative (glucose-repressed) AR system, named AR1 (Lin 
et al., 1995, Lin et al., 1996). Very little is known about the major players of 
this latter system, whereas many data, including transcriptional, regulatory 
and structural data, are available for the amino acid-dependent systems, some 
of which are depicted in Fig. 1.1 (Foster, 2004, Zhao & Houry, 2010, De 
Biase & Pennacchietti, 2012, Kanjee & Houry, 2013).  
In particular, the glutamate(Glu)-dependent and the arginine(Arg)-dependent 
AR systems, named GDAR and ADAR respectively, require the addition of 
glutamate or arginine during the challenge at pH 2.5. These two systems 
provide the most robust protection from extreme acid stress (Lin et al., 1995, 
Lin et al., 1996, Castanie-Cornet et al., 1999, De Biase et al., 1999). 
The GDAR system consists of the two homologous inducible glutamate 
decarboxylases GadA and GadB, and the antiporter GadC, for glutamate/γ-
aminobutyrate (GABA) antiport (Castanie-Cornet et al., 1999, De Biase et 
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al., 1999, Richard & Foster, 2004, Ma et al., 2012). The corresponding genes 
(i.e. gadA, gadB and gadC) are  expressed upon entry into stationary phase in 
rich medium (independently of pH), and further induced upon hypo- and  
hyperosmotic stress, or by log-phase growth in minimal medium containing 
glucose at a pH of 5.5 (De Biase et al., 1999, Castanie-Cornet & Foster, 
2001, Ma et al., 2003). The ADAR system consists of the inducible arginine 
decarboxylase AdiA and the arginine/agmatine antiporter AdiC (Castanie-
Cornet et al., 1999, Gong et al., 2003), whose expression is maximal in rich 
medium at acidic pH, under anaerobic conditions and in the presence of 
arginine (Lin et al., 1995).  
BA
 
Figure 1.1. AR systems in E. coli. (A) The Glutamine(Gln)-dependent system. GadC is an 
amino acid antiporter with specificity for Gln, Glu and GABA. Upon uptake, Gln is 
converted to Glu by the acid-activated glutaminase YbaS, with concomitant release of 
gaseous ammonia. Free ammonia neutralizes the excess of protons, thereby elevating 
intracellular pH. Glu can be either directly exported by GadC or further decarboxylated by 
GadA/B to generate GABA. (B) Schematic diagram illustrating the structural components 
(decarboxylase and antiporter) of the GDAR and ADAR systems for which the 
crystallographic structures are available. (Adapted from (Kanjee & Houry, 2013, Lu et al., 
2013)).  
 
The lysine- and ornithine-dependent systems provide a much more limited 
protection to extreme acid stress because the corresponding decarboxylases 
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possess a pH optimum of activity which is between 5.5-6.0 and therefore 
cannot provide protection when the intracellular pH drops to <5 as a 
consequence of an external pH of <2.5 (Kanjee & Houry, 2013).  
1.1.2 The GDAR system: function and regulation 
GDAR is by no doubt the major AR system in several food-borne 
pathogens and orally-acquired bacteria such as E. coli, Shigella flexneri, 
Lactococcus lactis and Listeria monocytogenes (Lin et al., 1995, Lin et al., 
1996, Sanders et al., 1998, Cotter et al., 2001, Bhagwat & Bhagwat, 2004). 
According to the proposed model for the GDAR system of E. coli (De 
Biase & Pennacchietti, 2012), when the extracellular proton concentration 
sharply increases to harmful levels (i.e. pH  2.5), as during transit through 
the host stomach, the inner membrane cannot avoid the passive entry of 
protons (and probably undissociated HCl), the intracellular pH drops and the 
import of Glu
0
 via GadC is triggered (Fig. 1.2) (Richard & Foster, 2004, Ma 
et al., 2012, Ma et al., 2013). Once inside, Glu remains protonated on the γ-
carboxylate to allow binding to and decarboxylation by GadA and GadB , 
which are maximally active in the pH range 4–5 (Shukuya & Schwert, 1960, 
Fonda, 1972, Pennacchietti et al., 2009). The α-carboxyl group, leaving as 
CO2, is thus replaced by a cytoplasmic proton, yielding GABA
+1
, which is 
exported via the functionally associated antiporter GadC in exchange for a 
new Glu molecule. The export of GABA
+1
 contributes to the net export of 
positive charges (0.9 H
+
/exchange cycle), further relieving from intracellular 
acidification (Tsai et al., 2013). 
 
7 
 
 
Figure 1.2. Glutamate-based acid resistance system. Schematic representation of the 
mechanisms (antiport + decarboxylation) required for its activity (De Biase & Pennacchietti, 
2012). 
 
In vivo studies on E. coli cells also showed that GDAR not only contributes 
to pH homeostasis but, by transiently accumulating GABA in the cell, it 
counteracts illicit entry of protons by inversion of the membrane potential 
(), a strategy similar to that adopted by extreme acidophiles (Foster, 
2004). Indeed, in E. coli grown at pH 7, in aerobic conditions, the  is -90 
mV and -50 mV in exponential phase in the stationary phase. When cells of 
E. coli are transferred to pH 2.5, in the presence of glutamate, their cytoplasm 
is acidified to a pH value equal to 4.5 and the  becomes positive (+30 mV) 
slowing down proton entry. Chloride channels performing the H
+
out/Cl
-
in 
antiporter have also been proposed to play an important role in AR system,  
by counteracting the excessive hyperpolarization of the membrane (Accardi 
& Miller, 2004, Foster, 2004). 
E. coli GadA and GadB are coded by the corresponding genes at 3665 kb 
and 1570 kb respectively (Fig. 1.3). The gadC gene is immediately 
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downstream of gadB with which it can be cotranscribed (De Biase et al., 
1999), whereas the distantly located gadA gene belongs to the acid fitness 
island (AFI), a 14 kb genome region, repressed by HNS (the histone like 
nucleoid-structuring protein) and controlled by RpoS (the stationary phase σ 
factor of the RNA polymerase) (Hommais et al., 2004, Weber et al., 2005). 
gadA can be either independently transcribed or co-transcribed with the 
downstream gadX gene (De Biase et al., 1999, Tramonti et al., 2002).  
AFI comprises 14 genes in the following operon arrangement: slp-yhiF, 
hdeAB-yhiD, gadE-mtdEF, gadXW and gadAX  (Fig 1.3) (Tramonti et al., 
2002, Tucker et al., 2003). Notably the AFI contains many genes coding for 
transcriptional regulators, which include YhiF, GadE, GadX, GadW, ArrS and 
GadY: the first two belong to the LuxR family, the second two belong to the 
AraC-family, whereas the last two are small RNAs, which affect the stability 
of the gadE and gadX transcripts respectively (Tramonti et al., 2002, Ma et 
al., 2003, Tucker et al., 2003, Opdyke et al., 2004, Tramonti et al., 2006, 
Tramonti et al., 2008, Aiso et al., 2011). GadE, GadX, GadW and GadY were 
all shown to positively affect the expression of the gadBC operon (Tramonti 
et al., 2002, Hommais et al., 2004, Tramonti et al., 2006). Besides gadA and 
the genes coding for the regulators, all the AFI genes contribute at various 
levels to AR: hdeA and hdeB code for pH-regulated acid stress periplasmic 
chaperones, which facilitate the refolding of acid-denaturated proteins in this 
cellular compartment (Hong et al., 2005, Kern et al., 2007); slp, yhiD and 
hdeD code for membrane proteins participating in the protection from acidic 
metabolites such as lactate, succinate and formate (Mates et al., 2007); the 
mdtE and mdtF genes code for multidrug exporters whose expression is 
induced in stationary phase and is GadX-dependent (Kobayashi et al., 2006, 
Nishino et al., 2008). 
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Figure 1.3. Genomic organization of the GDAR and AFI genes. Representation of the E. coli 
genome map with the location of the loci encoding GadA/B (red), GadC (blue), additional 
membrane proteins (orange), multidrug exporters (gray), acid stress periplasmic chaperons 
(magenta), LuxR-like transcriptional regulators (light green), AraC-like transcriptional 
regulators (green) and a small regulatory RNAs (yellow). The bent arrows show the 
transcripts’ start and length of the operons (De Biase & Pennacchietti, 2012). 
 
The activation of gadBC and the AFI genes occurs under many stress 
conditions, including entry into the stationary phase (i.e. nutrient limitation), 
acidic pH, high and low osmolarity, anoxia (De Biase et al., 1999, Weber et 
al., 2005, Hayes et al., 2006) and requires the direct or indirect control of the 
response regulator of the two-component systems EvgAS, RcsBC, PhoPQ, 
EnvZ/OmpR and TorRS (Bordi et al., 2003, Castanie-Cornet et al., 2007, Itou 
et al., 2009, Burton et al., 2010, Stincone et al., 2011). 
The expression of gadE, coding for the essential regulator GadE (Ma et al., 
2003) is under the control of three activation circuits which respond to 
different growth conditions: the EvgAS-YdeO circuit is operative in the 
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exponential phase of growth in minimal medium EG at pH 5.5 (Masuda & 
Church, 2002, Ma et al., 2004, Itou et al., 2009); the TrmE-dependent circuit 
is operative in stationary phase in unbuffered LB medium containing glucose 
(Gong et al., 2004); the GadX/GadW-dependent circuit (Tramonti et al., 
2002, Tramonti et al., 2006, Tramonti et al., 2008) is required for gadE 
activation upon entry into the stationary phase in buffered LB medium 
(Sayed et al., 2007). The latter circuit is the most complex and best 
characterized at the molecular level. Besides GadX and GadW, it involves the 
global transcriptional regulators H-NS and CRP, which act as repressors, and 
RpoS, which instead positively affects gadA and gadBC transcription (De 
Biase et al., 1999, Castanie-Cornet & Foster, 2001, Hommais et al., 2001, 
Tramonti et al., 2002, Giangrossi et al., 2005, Weber et al., 2005). 
 
 
Figure 1.4. Regulators cascade controlling the activation of GDAR system. In this scheme is 
emphasized the role of GadE as a central activator of the gad genes (Zhao & Houry, 2010). 
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Atypical is the role played by RcsB (not shown in Fig. 1.4) belonging to the 
sensor-regulator system RcsCB. In fact, the basal activity of this regulator is 
required for the expression of gadA and gadBC genes in the presence of 
GadE, whereas its activation, through the sensor RcsC, leads to a decrease of 
AR in the stationary phase (Castanie-Cornet et al., 2007, Castanie-Cornet et 
al., 2010). 
The intricate regulative network that allows in E. coli a fine tuning of gadA 
and gadBC expression in response to various environmental stimuli clearly 
indicates that the activity of the GDAR system must be timely controlled and 
also that its role might go beyond that of protecting from the extreme acid 
stress. 
1.1.3  The GDAR system: structural components 
In E. coli the two major structural components of the GDAR, GadB and 
GadC, display an acidic pH optimum (Pennacchietti et al., 2009, Ma et al., 
2012). The combination of crystallographic and site-directed mutagenesis 
studies has allowed to investigate on the molecular mechanisms underlying 
GadB and GadC activation, which share indeed amazing similarities. In fact 
both proteins undergo auto-inhibition at pH > 5.5 thanks to the occurrence in 
the C-terminal region of amino acid residues that organize into structures that 
plug either the active site (in GadB) or the substrate entry channel (in GadC). 
Notably, in both proteins histidine residues play an active role as gate-
keepers.  
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1.1.3.1 GadC 
GadC is a representative member of the amino-acid-polyamine-
organocation (APC) superfamily of membrane transporters, which also 
includes AdiC of the ADAR system. 
GadC is composed by 12 trasmembrane helices (TMs) which are arranged 
into two inverted repeats, contributed by TM1-TM5 and TM6-TM10, and of 
TM1 and TM6 each containing two short α-helices connected by a 
discontinuous stretch in the middle (Ma et al., 2012). The recently published 
structure of GadC was solved at pH 8.0 and shows the features of the inactive 
conformation (inward-open) of this protein (Ma et al., 2012). In fact in vivo 
and in vitro (i.e. proteoliposome-based) studies have shown that substrate 
transport by GadC is strictly pH-dependent, with robust activity at pH 5.5 or 
below and no detectable activity at pH  6.5. In sharp contrast, AdiC still 
allows moderate transport activity up to pH 8.0 (Fang et al., 2007). 
The path where the putative substrate-binding residues are located provides a  
negatively charged environment. The C-terminal portion of the protein 
comprises residues 477-511 which make the C-plug, structurally arranged so 
to completely block the path to the putative substrate-binding site (Fig 1.5; 
(Ma et al., 2012)). The deletion of the C-plug, in which several His and Arg 
residues contribute to the stability of the C-plug itself and to its interaction 
with other residues in the protein (making multiple hydrogen bonds), shifts 
the pH-dependent substrate transport towards higher pH values. As in the 
case of GadB (cfr. 1.1.3.2), the pKs of His residues in the C-plug could play a 
major role in controlling its displacement following intracellular 
acidification. The closed conformation of GadC is attained not only by the C-
plug in the cytoplasm but also by the L7 loop at the periplasmic side (Fig. 
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1.5). The substrate transport path is sandwiched axially between C-plug and 
L7 loop and surrounded by TM1-2-6-8-10. Thus, the displacement of both, 
the C-plug and the L7 loop, is a prerequisite for the transport activity of 
GadC. 
The structure of GadC, together with the availability of the structure of E. 
coli AdiC in the free (outward-open) and Arg-bound form (Fang et al., 2009, 
Gao et al., 2009, Kowalczyk et al., 2011), provides insights into the 
mechanism of substrate transport and helped to identify six gating residues in 
GadC (Ma et al., 2012) (Fig. 1.5). In fact, the six variants in which residues 
Tyr96, Tyr214, Glu18, Trp308, Tyr378 or Tyr382, all located near the 
putative transport path, were substituted into Ala, all show a significant 
decrease in substrate transport. Under the assumption of conserved transport 
mechanism between AdiC and GadC, the structural alignment 
(AdiCout/GadCin) allowed to identify an almost static core domain and a gate 
domain (TM1-2-6-7) that seems to rotate clockwise by 35°, resulting in an 
inward-open conformation. The proposed transport mechanisms consists in a 
rocking-bundle movement in which individual TMs largely retain their 
conformations. 
 
 
Figure 1.5. GadC structure and transport path. The six key residues considered essential in 
the transport path are shown in a close-up view in the right panel (from (Ma et al., 2012)).  
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Noteworthy GadC is highly selective in substrate transport. In addition to 
Glu, GadC also efficiently transports three additional amino acids: Gln and, 
to a smaller extent, Met and Leu (Ma et al., 2012). GadC selectively 
transports Glu
0
 and GABA
+
, indicating that the protonation state of a given 
substrate is crucial for transport and that side chain deprotonation of Glu and 
GABA at neutral pH impedes Glu/GABA exchange (Ma et al., 2013).  
Tsai et al. proposed that at a pH of 2.5 GadC (as well as AdiC (Tsai & Miller, 
2013)) uses a charge-based mechanism to recognize its substrates, suggesting 
that the outward-open conformation, hostile to the +1 valence (GABA
+
 and 
Glu
+
), might import both Glu
0
 and the less abundant Glu
-1
 (Tsai et al., 2013). 
The inward-open conformation, which needs to reject GABA
0
 and discharge 
Glu
0
 or Glu
−
, also adhere to this electrostatic picture. Moreover, in contrast to 
the current model (Foster, 2004), they proposed that GadC acting as a virtual 
proton-pump should polarize the membrane in the negative direction (Tsai et 
al., 2013). 
1.1.3.2 GadB 
The crystal structure of E. coli GadB was reported in 2003 (Capitani et al., 
2003). This was the first structure of a prokaryotic glutamate decarboxylase 
to be released, followed by those of E. coli GadA in complex with glutarate, a 
substrate analogue (Dutyshev et al., 2005), human Gad65 and Gad67 (Fenalti 
et al., 2007) and plant Gad1 (Gut et al., 2009). 
The crystallographic structure of wild type GadB was solved at both acidic 
pH (4.6) and neutral pH (7.6) and has provided insights on the molecular 
basis of its intracellular activation (Capitani et al., 2003). GadB is a 
homoexamer of 320 kDa that can be described as a trimer of dimers, the basic 
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catalytic unit in most PLP-dependent enzymes. The structure is arranged on 
two layers with each dimer contributing to both layer. The comparison of the 
structure of GadB obtained at the two values of pH provided evidence that 
the overall structure of the hexamer remains unaffected by the shift in pH 
change (Fig. 1.6). However, three major structural reorganization occur in the 
N- and C-terminal regions of each subunit and in a β-hairpin, which includes 
residues 300-313, thus leading to the conversion of GadB from the inactive 
into the active form and vice versa. 
In the neutral pH-structure (Fig. 1.6, on the left), residues 3-15 in the N-
terminal region are disordered. Nevertheless, via the narrow central channel, 
each N-terminal domain (residues 1-57) acts like a hook and contributes to 
stabilize the hexamer, i.e. it departs perpendicularly from the subunit surface 
and reaches the opposite layer where it make contacts both with the 
counterpart in the functional dimer and with a subunit belonging to a 
neighboring dimer. In the structure at pH 4.6 (Fig. 1.6, on the right), residues 
3-15 of each subunit assume an α-helix conformation, which close the central 
channel and give rise to two triple helical bundles, parallel to the threefold 
axis and protruding on each (top and bottom) side of the hexamer. This 
occurs only at acidic pH since the side chains of acidic residues in the N-
terminal regions become protonated, thus abolishing negative charges 
repulsion. Functional studies on the GadB∆1-14 deletion mutant, allowed to 
demonstrate that the formation of the triple helical bundles is required for the 
recruitment of the enzyme to the plasma membrane, where the protons are 
more abundant and its decarboxylase activity functionally match to that of the 
antiporter GadC (Capitani et al., 2003). 
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Figure 1.6. Side views of the E. coli GadB hexamer at neutral (left) and acidic (right) pH. 
(A) The two-layered GadB hexamer is shown in colors. Each dimer contributes to both 
layers. (B) Major conformational changes in GadB. The hexamer is in gray, but the 1–14 N-
terminal region (red), the 452–466 C-terminal tail (green) and the 300–313 β-hairpin 
(magenta). PLP is shown in filled space (yellow) (De Biase & Pennacchietti, 2012). 
 
Furthermore, the N-terminal regions contribute to the cooperativity of the 
system providing protonable residue side chains and surmount the halides 
binding sites. Of particular physiological relevance is the finding that 
chloride ions act as positive allosteric modulators (O'Leary & Brummund, 
1974) by strongly stabilizing the triple helical bundles (Gut et al., 2006). 
Indeed, in the variant GadB∆1-14 cooperativity in the absorbance change 
(indicative of the conversion between the active and inactive forms) is greatly 
reduced (n ≈ 2) and is insensitive to the presence of chloride ions. 
At neutral pH, the C-terminal residues 452-466 are well ordered and protrude 
into the active site of each monomer with residues His465 and Thr466 that 
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preclude the access to the binding site to Glu (Fig. 1.7). At acidic pH 
however the C-terminal tail is not visible in the active site and has not been 
possible to assign to this protein portion any electron density, probably as a 
consequence of increased conformational flexibility (Fig. 1.6; (Capitani et al., 
2003)). The area of access to the active site, left free after the displacement of 
the C-terminal tail from the active site, is accompanied by an increased 
accessibility of the active site, partially occupied by the β-hairpin region 
belonging from the neighboring subunit of the functional dimer. 
Biochemical (cfr. 1.2.1) and crystallographic studies provided evidence 
for the existence, at neutral pH, of a ternary complex, i.e. substituted 
aldamine, arising from reaction of the distal nitrogen of imidazole ring of 
His465 with the PLP-Lys276, which constitutes the catalytically inactive 
species (Fig. 1.7). Aldamine formation represents an elegant auto-inhibition 
mechanism, which ensures the enzyme to independently control its catalytic 
activity in a pH-dependent manner (Gut et al., 2006). The functional analysis 
of GadBH465A and GadB∆HT mutants, in which the residue His465 is 
replaced or deleted, respectively, demonstrated that in the absence of this 
residue the active site becomes accessible to the substrate and the enzymatic 
activity persists at pH values at which the wild-type enzyme is typically 
inactive (Pennacchietti et al., 2009). His465 is highly conserved in 
prokaryotic Gads and contributes to the cooperativity of the system 
(Pennacchietti et al., 2009). 
Experiments of cellular partition have pointed out that opening/closing of the 
active site of GadB does not affect the folding/unfolding of N-terminal triple-
helix bundles, required for membrane recruitment (Pennacchietti et al., 
2009). Conversely, the unfolding of the α-helices affects the rate at which the 
C-terminal ends regain access into the active site (Gut et al., 2006). 
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Figure 1.7. GadB active site at neutral pH. (A) Electron density map of substituted aldamine 
and residues involved in locking the active site (Phe463 to Thr 466). (B) Chemical structure 
of substituted aldamine. The arrow indicates the C4' carbon of the coenzyme which becomes 
sp
3
 hybridized and asymmetric (Gut et al., 2006). 
1.2  Glutamate decarboxylase 
1.2.1  Glutamate decarboxylases  
Glutamate decarboxylase (Gad; EC 4.1.1.15) is an essential enzyme 
present in eukaryotes and prokaryotes, in which it plays different  
physiological roles (Ueno, 2000). It catalyzes the irreversible α-
decarboxylation of L-glutamate to GABA (γ-aminobutyrate or 4-
aminobutyrate). 
Gad is a pyridoxal 5’-phosphate (PLP)-dependent enzyme. Members of 
this superfamily catalyze a range of important reactions, including α-
decarboxylation, transamination, racemization and aldol cleavage (Jansonius, 
1998), and many of these enzymes catalyze more than one reaction.  
Unlike the aminotransferases, that constitute a family of homologous 
proteins, the PLP-dependent amino acid decarboxylases seem to be evolved 
along multiple lineages (Sandmeier et al., 1994). The explanation for this 
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difference may be sought in the type of catalyzed reaction: transaminases 
react reversibly with two substrates, with a ping-pong mechanism, and 
generate changes not only in the covalent bond between C and the substrate, 
but also in the bond involving the C4' of the coenzyme. Thus, the complexity 
of the reaction could have prevented the evolution of aminotransferase 
according to multiple pathways. Instead the -decarboxylation of an amino 
acid is a simpler process: it consists in an irreversible reaction which occurs 
on the C of the sole substrate used in the reaction, for which in the course of 
evolution were introduced amino acid substitutions to favor specificity 
towards different substrates. 
Regarding the mechanism of action of PLP-dependent decarboxylases 
(Fig. 1.8), the transaldimination reaction leads to the formation of external 
aldimine so that the -carboxylic group is oriented perpendicularly to the 
PLP pyridine ring. To this follows the release of CO2 and, therefore, the 
formation of the quinonoid intermediate stabilized by the coenzyme. The 
protonation on C of the former substrate generates the enzyme-product 
complex, which is hydrolyzed with release of the corresponding amine. The 
PLP then reconstitutes the Schiff base with the lysine residue at the active site 
of the enzyme (internal aldimine). 
For many decarboxylases, it was observed that the quinonoid intermediate 
can undergo an alternative fate (Sukhareva, 1986): in fact the protonation on 
C4', rather than on the C, and subsequent hydrolysis leads to the formation 
of the corresponding aldehyde and pyridoxamine 5'-phosphate (PMP), 
resulting in enzyme inactivation (Fig. 1.8b). This type of side reaction is 
known as abortive decarboxylation-transamination. The ability of PLP-
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dependent enzymes to perform multiple reactions is clearly the result of an 
evolutionary reminiscence. 
  
 
 
 
Figure 1.8. Glutamate decarboxylase reaction mechanism. 
 
Based on multiple sequence alignment, the PLP-dependent decarboxylase 
have been divided into four distinct groups (Sandmeier et al., 1994). 
Glutamate decarboxylases belong to the group II, which includes the 
decarboxylases acting on glutamate, histidine, tyrosine and aromatic-L-
amino-acid.  
Gad is widespread among living organisms, with low sequence identity 
(12%) between the vertebrate (human GAD65) and bacterial (E. coli GadB) 
proteins. Conversely, plant (Arabidopsis thaliana Gad1) and bacterial 
enzymes (E. coli GadB) are more similar in terms of sequence identity (39%) 
as well as oligomeric assembly. 
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1.2.2  Biochemical insights into Escherichia coli GadB 
The kinetic properties of E. coli Gad reveal that it is highly specific for L-
Glu glutamate and pH-dependence of the activity, with a maximum activity 
at pH 4.5 (Fonda, 1972). In particular, the enzyme is catalytically active at 
pH < 5.5, while at pH > 5.5 is inactive. 
The two glutamate decarboxylase isoforms of E. coli, GadA and GadB, 
are 466 amino acids-long and differ in only 5 amino acid positions, four of 
which are located in the N-terminal region, while the last different residue is 
at position 153. The substitutions (GadA into GadB) are the following: 
Gln3Lys, Leu6Val, Phe9Leu, Ala22Ser and Asn153Asp. The separate 
overexpression and characterization of the two isoforms (De Biase et al., 
1996) indicated that the biochemical and kinetic properties of the two 
isoenzymes are identical, and also gave new impetus to structural studies for 
which purity and homogeneity of the starting material is a necessary 
precondition (Capitani et al., 2003). The GadB isoform is expressed in 
recombinant form at higher levels compared to GadA and for this reason was 
chosen for both structural and biochemical studies.  
The absorption spectrum of GadB varies as a function of pH (Fig. 1.9): at 
pH 4.5 the enzyme is catalytically active, has a yellow color and the 
coenzyme exhibits maximum absorption at 420 nm, while at pH 6 the 
enzyme is catalytically inactive, colorless and the chromophore displays 
maximum absorption at 340 nm. 
The pH-dependent spectroscopic events have been investigated in detail 
(O'Leary & Brummund, 1974, Tramonti et al., 2002): the transition from the 
inactive form (max. abs. 340 nm) to the active (max. abs. 420 nm) of GadB is 
a highly cooperative process as it involves the acquisition of 4-6 protons. 
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Figure 1.9. Absorption spectra of wild type GadB as a function of pH. In the region 300 nm - 
500 nm, the transition between the 420nm-absorbig species and the 340 nm-absorbing 
species is observed. The spectrum at pH 5.3 is the one closest to the pK of the spectroscopic 
transition. The inset shows the titration curve obtained by plotting the values of absorbance 
at 420 nm as a function of pH (Tramonti et al., 2002). 
 
Following the pH increase, however, the loss of as many protons generates 
the inactive species of the enzyme. Analysis by rapid kinetics of this 
interconversion have shown that the equilibrium is affected by halides 
(O'Leary & Brummund, 1974). In particular, their presence favors 340  
420 nm conversion, while significantly slows the conversion 420  340 nm. 
The enzyme activity therefore depends on these anions in solution according 
to the following scale of strength: I
-
 > Br
-
 > Cl
-
. Among these, chloride is the 
physiologically more relevant halide because it is abundant in gastric 
secretions and thus directly involved in the intracellular activation of GadB, 
as demonstrated by crystallographic data (Gut et al., 2006). 
The spectroscopic change as a function of pH has been attributed, similarly to 
other PLP-dependent enzymes, to a different chemical state of the coenzyme 
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that in the active site is linked to the -amino group of Lys276 (internal 
aldimine) (Fig. 1.10, left). In fact, while in a hydrated active site the internal 
aldimine is predominantly represented in the ketoenamine form, which 
absorbs at 420 nm, in a less hydrated active site the enolimine form, which 
absorbs at 340 nm, will be the most likely species. However, previews 
studies and, more recently, crystallographic and site-specific mutagenesis 
studies (Gut et al., 2006, Pennacchietti et al., 2009) led to the conclusion that 
the species with maximum absorption at 340 nm corresponds to the 
substituted aldamine as hypothesized (cfr 1.1.3.2). This arises from the 
reaction between the nitrogen of the imidazole ring of the residue His465 and 
Lys276-PLP Schiff base, resulting in a change of the hybridization state of 
the C4' of the cofactor from sp
2
 to sp
3
 (Fig.1.7; Fig.1.10). 
 
Figure 1.10. Chemical structure of ketoenamine (on the left), enolimine (center) and 
substituted aldamine (right) (Pennacchietti et al., 2009). 
 
In the last decade, crystallographic and biochemical studies allowed to 
identify the nature and the functional outcomes of the pH-dependent 
conformational changes (Capitani et al., 2003, Gut et al., 2006). On the other 
hand, the structural role of PLP concerning folding, oligomeric assembly and 
stability of the enzyme has not yet been fully investigated. The few available 
knowledge dates back to some decades ago, when E. coli GadB was first 
characterized in terms of biochemical and biophysical properties (for a 
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review (Sukhareva, 1986)). In the holo-form GadB is a hexamer, in which 
each subunit binds one PLP molecule (Shukuya & Schwert, 1960, 
Strausbauch & Fischer, 1970, To, 1971). The hexamer dissociates into 
inactive dimers when the enzyme is very diluted or when it is present in the 
apoenzymatic form and the pH of the solution is > 6 (Tikhonenko et al., 
1968) (Fig. 1. 11). This dissociation is reversed by the addition of PLP to 
apodimers: 3 equivalents of PLP are sufficient to reconstitute the hexamer, 
but the enzyme activity is fully restored only when 6 equivalents of 
coenzyme are added. 
 
+ 3 PLP
- 3 PLP
+ 3 PLP
pH 4.6pH  6
Enzyme
hexamer
50% active
Apoenzyme
hexamer
inactive
Apoenzyme
dimeric
Holoenzyme
hexamer
100% active
 
Figure 1.11. Interconversion between the hexameric and dimeric form of Gad. 
 
The structure of the active site of GadB ((Capitani et al., 2003); Fig. 1.7) 
has similarities with other fold-type I enzymes that belong to the structural 
family of aspartate aminotransferase. The residues Lys276, His275, Asp243 
and Ala245 are the ones who primarily participate in securing and properly 
orienting the coenzyme in the active site. Indeed, the -amino group of 
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Lys276 forms the Schiff base with the C4' of the PLP (Tramonti et al., 2002), 
the imidazole group of His275 interacts with the phosphate of the PLP 
(Tramonti et al., 1998), the carboxyl group of the Asp243 residue forms a salt 
bridge with the nitrogen N1 of the PLP pyridine ring and the methyl group of 
the residue Ala245 provides a hydrophobic contact with the pyridine ring 
(Capitani et al., 2003). However, some amino acid residues in the active site 
establish unusual interactions that have no counterparts in other 
decarboxylases belonging to the same structural family. For example, the 
pyridine ring of the cofactor establishes a hydrophobic interaction with the 
carbons in the side chain of Gln163. In other  PLP-dependent enzymes this 
interaction typically involves  contacts with the aromatic side chains of 
phenylalanine, tryptophan, tyrosine and histidine residues. Moreover, in the 
GadB active site there are three cysteine residues, Cys64, Cys130 and 
Cys165, the last two of which appear to be involved in the formation of a 
disulfide bridge (Capitani et al., 2003). The role of these residues has not 
been elucidated yet. 
An element of absolute novelty is represented by the occurrence at neutral pH 
of the last two residues at the C-terminal tail, i.e. His465 and Thr466, in the 
active site. As mentioned before, these two residues occupy approximately 
the position of the natural substrate, Glu. The residue Asp86 is one of the few 
residues of the active site that is provided by the other subunit of the 
functional dimer and is essential for the stabilization of -carboxyl group of 
glutamate at acidic pH values, i.e. when at least one of the two carboxyl 
groups is protonated. The residue Phe63 plays an important role in GadB as it 
precludes residue Arg422 to interact with the -carboxylic group of 
glutamate, which must be removed. It is noteworthy that in transaminases the 
residue that occupies the position of Arg422 in GadB is free to establish an 
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interaction with the -carboxyl group of the substrate, and this is 
indispensable for correct catalysis. 
1.2.3  Bacterial Gads  
E. coli GadB is definitely the most extensively characterised bacterial Gad 
(cfr 1.1.3.2 and 1.2.2). In fact only few reports dealing with the biochemical 
properties of other bacterial Gads have been published (Table 1.1). Among 
these, Gad from Clostridium perfrigens, a major cause of food poisoning in 
developed countries, was purified by homogeneity and partially characterized 
(Cozzani et al., 1970). It exhibits spectroscopic and kinetic properties, as well 
as the oligomeric assembly, resembling those of the E. coli enzyme. 
More recently, the increased interest in high GABA-producing strains of 
LAB (Lactic Acid Bacteria) for biotechnological applications (cfr. 1.3.1), led 
to the purification and functional analysis of Gads from Lactococcus lactis 
(Nomura et al., 1999), Lactobacillus paracasei (Hiraga et al., 2008) and 
partial characterization of Lactobacillus brevis (Komatsuzaki et al., 2008). 
Notably, highly heat stable Gads from the hyperthermophilic archaea 
Pyrococcus horikoshii (Kim et al., 2009) and Pyrococcus furiosus (Lee et al., 
2013) were purified as recombinant proteins and characterized for potential 
industrial applications. Compared to E. coli enzyme, the Gads from 
Pyrococcus species showed different biochemical features, such as an 
unusual monomeric assembly, a pH optimum in the neutral-alkaline range 
and broader substrate specificity (P. furiosus). 
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Table 1.1. Prokaryotic Gads. 
Species 
Subunit 
MW 
No. of 
subunits 
Max. Abs. 
(nm) 
pH 
optimum  
Km 
(mM) 
Sp. Act. 
µmol/ 
min/mg 
Ref. 
Escherichia coli 50 6 340-420 3,8-4,6 2,32 240-235 * 
Clostridium perfrigens 48-50 6 333-410 4,7 - 238§ 
(Cozzani et al., 
1970) 
Listeria monocytogenes - - - - 16 39 (Shah et al., 1981) 
Lactobacillus brevis 
IFO12005 
54 2-4 - 4,2-4.6 1-9,3 - 
(Ueno et al., 1997, 
Hiraga et al., 2008) 
Lactococcus lactis 54 - - 4,7 0,51 53,2 
(Nomura et al., 
1999) 
Lactobacillus paracasei 57 2 - 5 5 7,5 
(Komatsuzaki et al., 
2008) 
Pyrococcus horikoshii 42-45 1 - 8 3,9 - (Kim et al., 2009) 
Pyrococcus furiosus 41 1 340-420 6 2,22 - (Lee et al., 2013) 
Neurospora crassa 33 1 - 5 2,2 2,8 
(Hao & Schmit, 
1993) 
Aspergillus oryzae 48 6 - - 13,3 48,2 
(Tsuchiya et al., 
2003) 
*(Shukuya & Schwert, 1960, De Biase et al., 1996, Capitani et al., 2003, Pennacchietti et al., 2009)  
§ µl CO2/min/mg  
 
 
A ClustalW alignment generated with 20 bacterial Gads, mostly from 
Gram-positive and Gram-negative enteric bacteria, showed that 84 residues 
(18% of the E. coli GadB sequence) are strictly conserved (De Biase & 
Pennacchietti, 2012). Several of these residues are known to occupy critical 
positions in E. coli GadB, i.e. in or near the active site or at sites where the 
conformational changes occur. In addition to the 8 residues which are shared 
with group II decarboxylases (mainly involved in anchoring PLP and in 
structural roles), the concurrent presence of the residues listed in bold in 
Table 1.2 (numbering refers to E. coli GadB) may be regarded as the 
signature for bacterial Gad (De Biase & Pennacchietti, 2012). The latter 
residues play different roles and are: Asp86* (*from the neighboring subunit 
in the functional dimer), with its side-chain tilted towards the active site in 
the open conformation, interacts with the γ-carboxylate of the substrate 
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glutamate; Glu89* in the low-pH structure is not far away from Asp86*, from 
which in the neutral-pH structure it points in opposite direction (Capitani et 
al., 2003); Gln163 with its side-chain alkyl portion acts as stacking residue 
for the PLP ring; Thr62 side chain hydroxyl and Phe63 amide nitrogen 
provide additional hydrogen bonds to the γ-carboxylate of the substrate; 
Phe63 with its side-chain ring plays also an important role in preventing the 
binding of the α-carboxylate of glutamate to Arg422; His275, preceding the 
PLP-binding residue Lys276, is critical for keeping the cofactor in place by 
making an hydrogen bond with an oxygen of the PLP phosphate group via its 
side-chain τ nitrogen (Tramonti et al., 1998, Capitani et al., 2003); Tyr305* 
and Leu306*, at the tip of the β-hairpin 300–313, interact with residues 461–
463 at the C-terminus in the inactive form; Tyr305* in addition may be 
involved in protonating the substrate during the decarboxylation reaction, just 
as reported for Tyr332 in 3,4-dihydroxyl-L-phenylalanin (L-DOPA) 
decarboxylase (Bertoldi et al., 2002); His465 is responsible for GadB auto-
inhibition via formation of the substituted aldamine (cfr. 1.1.2.2; (Gut et al., 
2006, Pennacchietti et al., 2009)). 
Notably, the residue corresponding to E. coli GadB His465 is not present in 
the GadB homologue from Lactobacillus brevis ATCC367. The absence of 
this residue may be explained by the different structural organization of this 
enzyme. Hiraga et al. (Hiraga et al., 2008) showed that Gad from L. brevis 
IFO12005 is dimeric in the inactive form and tetrameric in the active. 
Treatment of Gad with high concentrations of ammonium sulphate and 
subsequent dilution with sodium glutamate were essential for tetramerization 
and activation. Gad from L. paracasei was also reported to be dimeric 
(Komatsuzaki et al., 2008). 
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Table 1.2. Amino acid residues composing the bacterial Gad signature. 
 
Residue
a 
Role
Thr62 (side chain OH) Binding of substrate γ-carboxylate
Phe63 (amide N) Binding of substrate γ-carboxylate
Phe63 (side chain) Prevents Arg422 binding to substrate α-carboxylate
Asp86* (β-carboxylate) Binding of substrate γ-carboxylate
Glu89* (side chain) Significant change in orientation upon pH-shift
Gly120
b 
Structural role
Ser126 (amide N) Hydrogen bond with PLP phosphate oxygen
Ser127 (side chain OH) Hydrogen bond with PLP phosphate oxygen
Gln163 (alkyl chain) PLP stacking
Gly210 Probable structural role
Thr212 (side chain OH) Interacting with PLP OH (intramolecular proton transfer?)
His241 (side chain π N) Hydrogen bond with Ser269
Asp243 (β-carboxylate) Interacting with the pyridine N of PLP
Ala245 (side chain) Hydrophobic contact with the pyridine ring of PLP
Ser269 (side chain OH) Hydrogen bond with His241
His275 (side chain τ N) Hydrogen bond with PLP phosphate oxygen
Lys276 (e-amino group) Forming the Schiff-base with the C4’ of PLP
Tyr305* (side chain OH) Interacts with residues 461–463 of the C-terminus (reprotonation?)
Leu306* Interacts with residues 461–463 of the C-terminus
Gly307* In the β-turn of β-hairpin 300–313
His465 (side chain τ N) Covalent bond with PLP-Lys276 Schiff base
a. Numbering refers to E. coli  GadB.
b. Residues in plain text are the residues strictly conserved in the decarboxylases of the PFAM PF00281.
The asterisk ‘*’ indicates residues contributed by the neighbouring subunit in the functional dimer.
(Adapted from (De Biase & Pennacchietti, 2012)) 
 
Although the GDAR system was shown to play a pivotal role in the acid 
resistance of several orally-acquired bacteria, the corresponding Gads have 
not been characterized at the molecular level. For example Gad from the 
food-borne pathogen L. monocytogenes was only partially purified (Shah et 
al., 1981). A potentially functional gadBC operon is present in the genome of 
several bacterial species. For instance in Brucella microti, a recently 
described, fast-growing Brucella species, the gadB and gadC genes are intact 
(Audic et al., 2009). The role of GDAR system in B. microti was recently 
investigated (Occhialini et al., 2012). GadB from B. microti, which shares 
73% sequence identity with E. coli GadB, was purified as recombinant 
protein and extensively characterized in this thesis work. 
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1.2.4  Eukaryotic Gads 
In the four last decades, several studies have been carried out to elucidate 
the physiological role and the functional properties of Gad in Eukaryotes 
(Tab 1.3), i.e. vertebrates and plants. 
 
Table 1.3. Eukaryotic Gads. 
Species 
Subunit 
MW 
No. of 
subunits 
Max. 
Abs. 
(nm) 
pH 
optimum  
Km 
(mM) 
Sp. Act. 
µmol/ 
min/mg 
Ref. 
Mouse 44 2 - 7 0,7 2 (Wu et al., 1973) 
Human 67 2 332-422 6,8 1,3 1 
(Blindermann et al., 
1978, Chen et al., 
1998) 
Porcine α-β-γ 60 2 - 6,2-6,5 
0,17- 
0,45- 
1,25 
0,48- 
1,2- 
2,3 
(Spink et al., 1985) 
Chicken 62, 59 2 - - - 2,6 (Gottlieb et al., 1986) 
Rat 40-80-44 2 - 7,3 1,6 2,4 (Denner et al., 1987) 
Feline 59 2 338-420 6.6 1,37 3,25 (Chu & Metzler, 1994) 
Human GAD65 65,4 2 332-422 - 1,41 - 
(Chen et al., 1998, 
Battaglioli et al., 2003, 
Fenalti et al., 2007) 
Human GAD67 66,6 2 - - 0,33 - 
(Battaglioli et al., 
2003, Fenalti et al., 
2007) 
Monkey 61 - - 7 - 0,0011 (Inoue et al., 2008) 
Squash - - - 5,8 8,3 25,8 
(Matsumoto et al., 
1986) 
Soybean - - - 5,8 9 1,1 (Snedden et al., 1995) 
Petunia 58 - - 5-6 8,2 30 (Snedden et al., 1996) 
Arabidopsis 
thaliana Gad1 
57,1 6 338-425 6 - 33,6 
(Zik et al., 1998, Gut 
et al., 2009) 
Arabidopsis 
thaliana Gad2 
56,1 - - - - 20,1 (Zik et al., 1998) 
Locust 51 2 - 7,2 5 1,10 (Stapleton et al., 1989) 
Saccaromyces 
cerevisiae 
66 - - 5 - - (Coleman et al., 2001) 
 
Recently, the structures of the two isoforms of human Gad (GAD65 and 
GAD67) and of the Arabidopsis thaliana Gad1 isoform were disclosed 
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(Fenalti et al., 2007, Gut et al., 2009), providing structural evidences of the 
diversified functional properties of Gads in living organisms. 
Although prokaryotic and eukaryotic Gads all possess the PLP fold typical of 
the largest of the PLP-dependent enzyme families (Momany et al., 1995), 
each Gad is unique in terms of distinctive structural features, such as mobile 
loops (human), a calmodulin binding domain (plant) or regions undergoing 
pH-dependent conformational changes (E. coli), relevant for activity in the 
corresponding organism (De Biase & Pennacchietti, 2012). 
In mammals, Gad exists as two isoforms, named GAD67 and GAD65, 
encoded by different, independently regulated genes. Human Gads maintains 
the physiological supply of GABA, the most abundant inhibitory 
neurotransmitter of the CNS and control fundamental processes such as 
neurogenesis (Fagiolini et al., 2004, Ge et al., 2006), movement and tissue 
development (Nakatsu et al., 1993, Asada et al., 1997, Kash et al., 1997). 
Altered GABA-mediated signaling is likely to play a role in a number of 
pathological conditions including Parkinson’s disease, epilepsy, 
schizophrenia, autism, anxiety and bipolar disorder (Treiman, 2001, Akbarian 
& Huang, 2006, Thompson et al., 2009, Lanoue et al., 2010). Moreover 
GABA and Gad are present in several non-neuronal tissues including the 
pancreatic β-cells, from which GABA is released to regulate glucagon 
secretion by α-cells (Rorsman et al., 1989), the adrenal medulla and the 
gastrointestinal tract (Tillakaratne et al., 1995).  
The two isoforms can undergo different post-translational modifications 
(Christgau et al., 1992), have different intracellular distributions (Esclapez et 
al., 1994) and are found in soluble and membrane-bound states (Dirkx et al., 
1995). GAD67 is constitutively active and is responsible for basal GABA 
production, while GAD65 is transiently activated in response to an additional 
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demand for extra GABA in neurotransmission (Asada et al., 1996, 
Soghomonian & Martin, 1998), for example in response to stress (Kash et al., 
1997, Kash et al., 1999). GAD65 exists predominantly in an inactive apo-
form that can be rapidly activated via PLP supply. 
Initial studies on preparations of the porcine enzyme revealed that Gad can 
undergo an abortive decarboxylative-transamination that produces succinic 
semialdehyde and pyridoxamine-5’-phosphate, which readily dissociates 
from the enzyme, leaving it as inactive apoenzyme (Porter et al., 1985). 
Studies on human recombinant Gad showed that GAD65 is at least 15 times 
more efficient than GAD67 at catalyzing this side reaction, which leads to 
rapid loss of enzyme activity (Battaglioli et al., 2003). It has been suggested 
that this represents a key mechanism for the control of GABA production.  
Both isoforms of human Gad are dimeric, with the two active sites formed at 
the dimer interface. Structural and mutational data reveals that each active 
site is substantially covered by an extended loop (residues 432–442, termed 
the ‘catalytic loop’) contributed in trans by the other monomer (Fig. 1.12) 
(Fenalti et al., 2007).  
In GAD67 the catalytic loop is well ordered and provides the conserved 
residue Tyr434 in the correct orientation to allow protonation at the Cα 
position (Fig 1.12 b,c). The dynamic conformation of the catalytic loop is 
crucial in the inactivation of GAD65 (Fenalti et al., 2007). In fact, in GAD67 
the continuous presence of Tyr434 in the correct orientation favors 
protonation of the Cα atom and uninterrupted GABA production, whereas  in 
GAD65 it is mobile and its flexibility causes the transient displacement of the 
catalytic tyrosine from the active site thereby rendering it more exposed and 
allowing protonation at C4’. This in turn leads to SSA production, release of 
PMP and enzyme autoinactivation. 
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Figure 1.12. Dimeric structure of human GAD67. (a) The N-terminal (blue), PLP-binding 
(cyan) and C-terminal (green) domains are labelled. Monomer A is colored slightly lighter 
than monomer B. In the active sites: Lys405-PLP Schiff base and PLP-GABA (orange 
spheres) and bound GABA (yellow spheres). The catalytic loop forms a flap over the active 
site of an adjacent monomer in trans and is colored magenta in each monomer. (b, c) Active 
sites of GAD67, showing a close-up of Lys-PLP (shown as orange sticks), PLP-GABA (dark 
grey) and non-covalently bound GABA (yellow) moieties. In the active site of monomer A, 
the side chain hydroxyl group of Tyr434 (magenta) forms a hydrogen bond to the Nε2 of 
His291, and would be 2.8 Å from the protonation site (Cα) of a PLP-GABA moiety (grey, in 
active site B). In the active site of monomer B, Tyr434 is flipped to an alternative 
conformation where it interacts with the backbone nitrogen of Tyr292 (adapted from (Fenalti 
et al., 2007)). 
 
A recent study revealed that the C-terminal domain also plays a critical role 
in the autoinhibition process via stabilizing the catalytic loop (Langendorf et 
al., 2013). GAD65, but not GAD67, is autoantigenic, with autoantibodies 
characteristically detectable in type 1 diabetes, autoimmune polyendocrine 
syndrome (APS), and more rarely in neurological disorders, i.e. Stiff-Person 
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syndrome (Solimena et al., 1988, Solimena et al., 1990), Batten's disease 
(Ramirez-Montealegre et al., 2005), cerebellar ataxia (Honnorat et al., 2001) 
and epilepsy (Peltola et al., 2000). The high-resolution crystal structures of 
both isoforms in combination with the epitope-mapping reveal key 
differences that correlate with known epitope regions in the antigenic isoform 
GAD65 (Arafat et al., 2009, Fenalti & Buckle, 2010). Specifically, the above 
mentioned flexibility in GAD65 at the C-terminal domain and catalytic loop, 
a property that is required for enzymatic function, may be the cause of the 
increased B-cell antigenicity. 
 
In plant, Gad is involved in development (Baum et al., 1996) and stress 
response (Bouche et al., 2004). Recent findings suggest that GABA also has 
a role as a signaling molecule in plants (Bouche & Fromm, 2004). 
Plant Gad exhibits two independent level of regulation: one is pH-dependent, 
providing an acidic activity maximum (pH 6), and the other is Ca
2+
-
dependent and mediated by Ca
2+
/calmodulin (CaM) binding, which is most 
efficient at pH 7.5. Thanks to this two-level regulation, Gad can flexibly 
respond to different kind of cellular stress occurring at different pH: at 
physiological pH, Ca
2+
/CaM-mediated Gad activation is required to respond 
to abiotic stress, whereas the acidic pH-dependent level of regulation might 
be involved in tissue wounding by larval footsteps and herbivores, which 
causes cytoplasm acidification as consequence of the release of vacuolar and 
apoplastic protons (Bown et al., 2006). 
In the model plant Arabidopsis thaliana, five Gad isoforms exist. Among 
them two, i.e. Gad1 and Gad2, have been biochemically characterized (Zik et 
al., 1998). The X-ray crystallographic structure of the root-specific isoform 
Gad1 (Fig. 1.13) is similar to that of E. coli GadB, with which it shares the 
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same fold and oligomeric assembly (Gut et al., 2009). Moreover, the active 
site and the cofactor binding mode are well conserved.  
 
 
Figure 1.13. Crystal structure of A. thaliana Gad1. (a and c) Surface representations of the 
Gad1 homohexamer. View along the 3-fold (a) and the 2-fold (c) non-crystallographic 
symmetry axes of the protein. (b) Cartoon representation of Gad1. The six subunits are 
depicted in different colors. (Gut et al., 2009). 
 
Conversely, the key functional modules at the N-terminal and C-terminal 
regions of Gad1 differ significantly, reflecting adaptations to different 
function and regulation. 
Similarly to E. coli GadB N-terminal domain has an important role in the 
formation and stabilization of the dimer and hexamer, while the triple helical 
bundles and the halide binding sites, typical of E. coli GadB, are not 
conserved. The C-terminal domain consists of a linker of approx. 20 residues 
followed by the well characterized and conserved CaMBD (CaM Binding 
Domain), which regulates enzyme activity in a CaM-dependent manner. 
According to a low-resolution structure by small-angle X-ray scattering 
(SAXS), CaM actives Gad1 in a unique way (Fig. 1.14): one CaM1 molecule 
attaches to two Gad1-CaMBDs of the neighboring subunits in a 
homoexameric enzyme, activating two adjacent active sites by relief of the 
corresponding autoinhibitory domains (AIDs) (Gut et al., 2009). 
36 
 
 
Figure 1.14. Domain organization of Gad1 and CaM-binding mode. (a) Cartoon 
representation of the Gad1–CaM1 complex from the SAXS model. Each Gad1 subunit is in a 
different colour, and the CaM molecules are in red. (b) Gad1 subunits are depicted as a 
cartoon with the linker atoms as spheres. Subunit B is in blue, subunit A is colour-coded by 
domain: N-terminal domain, magenta; large domain, cyan; small domain, orange; C-terminal 
linker, grey spheres; CaMBD, grey. CaM (red) is depicted as a cartoon with bound Ca2
+
 as 
green spheres. The cofactors of two adjacent active sites appear in space-fill mode. (Gut et 
al., 2009) 
 
According to the model proposed for the regulation of Gad1 activity (Gut et 
al., 2009) the AID of Gad1 folds into the active site in a pH-dependent 
fashion, and the ionization state of K496-K497 influences the tautomerization 
equilibrium of PLP and enzyme activation. The affinity of AID for the active 
site is stronger at pH above 6.9, resulting in the prevalence of the 338 nm-
absorbing enolimine tautomer and consequent autoinhibition. A pH below 
6.9 destabilizes the folded-CaMBD and results in the unfolding of this 
domain with a shift to the 415-nm-absorbing ketoenamine form of PLP. In 
the Gad1-CaM1 complex: CaM1 wrapped around two CaMBDs, keeps two 
AIDs away from the respective active sites and the cofactor is in its 
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ketoenamine form over the entire pH range. Notably, CaM1 enhances the 
activity of Gad1 more effectively at neutral-to-high pH, where C-termini are 
folded over the active sites. 
1.3  Biotechnological aspects 
1.3.1  GABA production by GDAR system in health and disease  
In mammals GABA exherts well-known physiological functions such as 
neurotransmission, induction of hypotension, and diuretic and tranquilizer 
effects (Wong et al., 2003). GABA is also employed for treatment of 
sleeplessness, depression, and autonomic disorders (Okada et al., 2000), 
chronic alcohol-related symptoms (Oh et al., 2003) and stimulation of 
immune cells (Oh & Oh, 2003). In addition, GABA was reported to be a 
strong secretagogue of insulin (Adeghate & Ponery, 2002), to promote the 
healing process of cutaneous wounds (Han et al., 2007) and to enhance 
survival of dermal fibroblasts exposed to oxidative stress (Ito et al., 2007). 
Owing to these physiological functions, several GABA-enriched fermented 
food, such as yogurt, cheese, green tea, rice germ (Abe et al., 1995, Oh et al., 
2003, Hayakawa et al., 2004, Zhang et al., 2006, Park & Oh, 2007) are 
considered commercially promising functional foods (Gobbetti et al., 2010). 
Functional foods were first described by M. Roberfroid as “food similar in 
appearance to conventional food that is intended to be consumed as part of 
the normal diet, but has been modified to sub-serve physiological roles 
beyond the provision of simple nutrient requirements” (Roberfroid, 1999). 
The health benefits of fermented functional foods are expressed either 
directly through the interactions of ingested live microorganisms with the 
host (probiotic effect) or indirectly as the result of the ingestion of microbial 
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metabolites synthesized during fermentation (biogenic effect) (Stanton et al., 
2005). 
Some food substrates (e.g. whey milk and grape must) could be enriched in 
GABA by fermentation with high GABA-producing LAB strains (Nomura et 
al., 1998, Siragusa et al., 2007). For example in a recent work it was shown 
that grape must fermented with L. plantarum DSM 19463 yields Gad-derived 
GABA at mM levels (Di Cagno et al., 2010). The resulting freeze-dried 
preparation together with GABA, contained niacin, minerals, and 
polyphenols due to the use of grape must. Although the primary use of this 
preparation is as a functional food supplement, it can also find application in 
dermatology. In fact, following application to Skin Ethic Reconstructed 
Human Epidermis, it induces the expression of human genes involved in skin 
protection, i.e. β-defensin-2, hyaluronan synthase and filaggrin (Di Cagno et 
al., 2010). This intriguing finding might open the way to new strategies for 
antimicrobial therapy in cosmetics. 
1.3.2  The application of glutamate decarboxylase in the 
manufacturing of biobased industrial chemicals 
Glutamic acid is a non-essential amino acid and is the most abundant 
amino acid in many plant proteins. Agricultural surplus and waste stream 
from biofuel production are now being considered as a low cost sources of 
glutamate for biotechnological conversion into GABA, and production of 
bio-based chemicals (Lammens et al., 2012). Examples of protein-containing 
materials are bioethanol byproduct streams such as DDGS (dried distiller’s 
grains with solubles, from maize and wheat) or vinasse (from sugarcane or 
sugar beets), but also plant leaves, natural oil or biodiesel byproducts, and 
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slaughterhouse waste. In the future algae could also provide an additional 
source for biodiesel and also Glu. 
Currently the proteins from plant leaves usually exit from biorefinery either 
in the form of fertilizers or in the form of animal feed. The protein-rich 
fraction of plants can be further split into more- and less-nutritious fractions, 
for example by hydrolyzing the proteins and separating the essential 
(nutritious) from the non-essential (less nutritious) amino acids. Non-
essential amino acids (e.g. glutamic acid, aspartic acid), with no significant 
value for food or feed could be very suitable raw materials for preparing 
(highly) functionalized chemicals, traditionally prepared by the 
petrochemical industry. 
Nitrogen containing molecules production usually involves reactions of 
molecules, such as propylene with ammonia, in very energy-intensive process 
(Veatch et al., 1960). Amino acids already contain nitrogen and can represent 
the starting material to by-pass the use of ammonia for the synthesis of 
nitrogen containing bulk chemicals (Scott et al., 2007). In this way it is 
possible to find new ways to decrease our dependency on fossil fuels. 
The structure of glutamic acid resembles many industrial intermediates, so a 
variety of chemicals could be made from it using a relatively limited number 
of steps. Examples of nitrogen-containing molecules that can in theory be 
produced from glutamic acid are the lactams N-methylpyrrolidone and N-
vinylpyrrolidone (Fig. 1.15). They are cyclic compounds containing four 
carbons, of which one is oxidized and involved in an amide bond with a 
nitrogen in the ring. N-methylpyrrolidone (NMP) is an industrial solvent that 
is used in the manufacture of plastics and as an ingredient in paint removers. 
N-vinylpyrrolidone (NVP) finds applications in the manufacturing of 
poly(vinylpyrrolidone) and copolymers, for example together with vinyl 
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acetate and methyl acrylate. Further it is used as solvent in the production of 
inks and paints, as an additive in the cosmetics industry, and in the 
pharmaceutical industry for the production of a disinfectant. 
On the pathway from glutamic acid to a range of molecules, decarboxylation 
of glutamic acid to GABA, enzymatically performed by Gad, is an important 
reaction. GABA in fact can be an intermediate from which various other 
chemicals can be synthesized, such as pyrrolidones. This can be done by 
combining the enzymatic decarboxylation performed by Gad with the one-pot 
cyclization of GABA to 2-pyrrolidone and methylation to form NMP 
(Lammens et al., 2010). By not fully converting 2-pyrrolidone into NMP, 
part of it could also be used for the simultaneous production of NVP. Another 
interesting material  synthesized by ring-opening polymerization of 2-
pyrrolidone is Nylon 4 (Park et al., 2013), a four-carbon polyamide suitable 
for application as an engineering plastic due to its superior thermal and 
mechanical properties (Cho et al., 2011). Contrary to other nylon polymers, 
nylon 4 is heat-resistant, biodegradable, biocompatible and compostable 
(Tokiwa et al., 2009). 
 
Figure 1.15. The pathway from glutamic acid to pyrrolidone-based chemicals (Adapted from 
(Lammens et al., 2011)). 
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Bio-based synthesis of GABA can be achieved either by whole cell reaction 
employing natural and recombinant microorganism or by purified Gad. Many 
prokaryotic Gad have recently been overexpressed in different bacteria such 
as E. coli (Le Vo et al., 2011), L. brevis (Park & Oh, 2007, Se-Hee Kim, 
2007), B. subtilis (Park & Oh, 2006) and B. longum (Park et al., 2005). 
However, using whole cells has disadvantages such as the decomposition of 
the product by GABA transaminase or the possible decrease in activity due to 
lack of nutrients for the cells. The use of purified Gad seems to be 
economically more feasible because of the simplified downstream 
purification of GABA from less complex reaction conditions. Recent reports 
have described Gad immobilization for re-use, like GadB immobilized on 
calcium alginate beads in bioreactor (Lammens et al., 2009), Gad 
immobilized as fusion protein to a cellulose-binding domain (Park et al., 
2012) and Gad immobilized to metal affinity gel (Lee et al., 2013). 
Moreover, engineered E. coli GadB, such as a C-terminal truncated mutant 
(Yu et al., 2012), His465 mutants (Pennacchietti et al., 2009) and 
Glu89/His465 mutants (Ho et al., 2013) were designed with the aim of 
improving the enzymatic properties of Gad and the reaction conditions for 
potential industrial applications. 
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1.4 Aims 
The scientific relevance of studying glutamate decarboxylase resides in its 
diversified physiological role and functional properties in living organisms. 
In humans alterations of GABA-signaling and autoantibodies anti-Gad have 
been related to neurological disorders (Treiman, 2001, Lanoue et al., 2010) 
and autoimmune diseases (Lernmark, 1996) respectively. 
Bacterial glutamate decarboxylases are interesting both for their 
physiological role in GDAR system (De Biase & Pennacchietti, 2012) and for 
the understanding of structure-function relationships in decarboxylases. 
Furthermore, exploring the catalytic mechanism, the molecular basis for 
enzyme activation/inactivation, and the role of PLP in the folding and 
oligomeric state of this enzyme is of relevance as it may have implications in 
both biomedical and biotechnology fields. In the latter case, glutamate 
decarboxylase reaction can find applications in the production of GABA-
enriched functional food (Di Cagno et al., 2010) and manufacturing of bio-
based industrial chemicals using GABA as an intermediate for the synthesis 
of biopolymers (Lammens et al., 2009). 
Glutamate decarboxylase (GadB) from E. coli has been extensively 
studied in our laboratory for many years. This thesis work has been 
undertaken with the aim of better understanding the functional role of 
specific amino acid residues involved in substrate binding and control of the 
enzyme activity in E. coli GadB. In addition, in order to gain further insights 
into the structural features of GadB apo form and the role of PLP in protein 
folding, a preliminary structural study on dimeric apoGadB was carried out. 
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To date, except for E. coli GadB, there are no reports on an in-depth 
functional, biochemical and spectroscopic characterization of bacterial Gad. 
Therefore, one of the goals of my work was to investigate whether the pH-
dependent molecular mechanisms controlling E. coli GadB activation are also 
conserved in other bacterial Gads, such as GadB from B. microti, in which 
the role of GDAR system was recently investigated (Occhialini et al., 2012). 
Thus, GadB from B. microti was expressed and purified as recombinant 
protein in a laboratory strain of E. coli, and extensively characterized at the 
biochemical level. 
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Materials and Methods 
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2.1  Growth media, bacterial strains and plasmids 
Bacteria were grown in the following media, which were sterilized in 
autoclave for 20 minutes at 120°C before use: LB, pH 7.4; SOB, pH 7.5; 
SOC (SOB supplemented with 0.2% glucose and 10 mM MgCl2); 2XL, pH 
7.5; SB, brought to pH 7.5 with 50 mM potassium phosphate buffer, pH 7.5 
(Sambrook et al., 1989); LB agar (LB containing 15 g/l Bacto Agar). 
Antibiotics were added to the growth media at the following concentrations: 
ampicillin (100 µg/ml), kanamycin (25 µg/ml), and chloramphenicol (34 
µg/ml). Bacto-tryptone, yeast extract and Bacto-agar are from Difco (BD & 
Co., France). 
The wild type E. coli K12 and B strains and plasmids used in this work are 
listed in Table 2.1. 
 
Table 2.1. E. coli strains and plasmids used in this study. 
Bacterial strains Genotype Source 
MG1655 F-, λ-, rph-1 GSC7740 
MG1655ΔgadAΔgadB 
MG1655 knockout mutant, in which gadA and gadB 
genes are deleted 
(Occhialini et 
al., 2012) 
MG1655ΔgadAΔgadBC 
MG1655 knockout mutant, in which gadA, gadB and 
gadC genes are deleted  
D. De Biase 
(unpublished) 
CC118 
F-, araD139, ∆(ara, leu)7697, ∆lacX74, phoA∆20, 
galE, galK, thi,rpsE, rpoB, argEam, recAl  
(Manoil & 
Beckwith, 
1985) 
StrataClone SoloPack F-, r-, endA-, recA-, tonA-, cre, lacZΔM15, SmR Stratagene 
BL21(DE3) F-, ompT, hsdSB (rB
-mB
-), dcm, gal, lon, λ(DE3) 
(Studier et al., 
1990)  
DH5-T1R 
F-, recA1, endA1, hsdR17(r-k,m
+
k), supE44, thi-1, 
gyrA96, relA1, deoR, phoA,(lacZYA-argF) 
U169[80 lacZM15], tonA 
Invitrogen 
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JM109 
F'[traD36, proA+, proB+, lacIq, lacZ(M15)], 
recA1, endA1, gyrA96(NalR), thi, hsdR17(r-k,m
+
k), 
supE44, relA1, (lac-proAB), mcrA 
(Ausubel et al., 
1987) 
Plasmids 
pBBR1MCS 
Expression plasmid (4707 bp): lac, T3 and T7 
promoters, CAT/CamR. 
(Kovach et al., 
1994) 
pBBR-gadBC_Bm 
pBBR1MCS containing a 3523-bp genome 
fragment from B. microti CCM4915, inserted 
between PstI and XbaI restriction sites. 
(Occhialini et 
al., 2012) 
pBBR-gadBC_Ec 
pBBR1MCS containing the gadB-gadC genomic 
region of E. coli. 
(Occhialini et 
al., 2012) 
pSC-A 
Cloning plasmid (4.3 kb): pUC ori, f1 ori, Plac, 
lacZ, neo (KanR), bla (AmpR), loxP, PCR product 
insertion site. 
Stratagene 
pSC-A_Bm-gadB 
pSCA containing a PCR product of 1395 bp, from 
pBBR-gadBC_Bm and corresponding to the gadB 
ORF from Brucella microti. 
This study 
pET3a 
Expression plasmid (4640 bp): pBR322 origin, T7 
promoter, bla (AmpR) 
Novagen 
pET3a_Bm-gadB 
pET3a containing a fragment of 1395 bp (gadB 
ORF from Brucella microti) inserted between NdeI 
and BamHI restriction sites. 
This study 
pQE60 
Expression plasmid (3429 bp): ColE1 ori, PT5-lacO 
RBSII, bla (AmpR) 
Qiagen 
pQgadB 
pQE60 containing a fragment of 1411 bp (1398 bp 
gadB ORF and 13 bp downstream) inserted 
between NcoI and HindIII restriction sites. 
(De Biase et 
al., 1996) 
pQgadBH465A 
pQgadB in which the fragment gadB EcoRV-
HindIII (639 bp) is replaced by a 639-bp fragment, 
containing the mutation H465A, obtained by PCR 
and digested with EcoRV-HindIII. 
(Pennacchietti 
et al., 2009) 
pQgadBD86N 
pQgadB in which the Asp86 has been mutated to 
Asn using the Gene Tailor system (Invitrogen) 
which inserts the mutation by amplification of the 
entire plasmid. 
(Pennacchietti 
et al., 
submitted to 
FEBS) 
pQgadBD86N-H465A 
pQgadB in which the fragment gadBH465A NcoI-
EcoRV (771 bp) is replaced by a 771-bp fragment, 
containing the mutation D86N, obtained by 
digestion with NcoI-EcoRV from pQgadBD86N. 
(Pennacchietti 
et al., 
submitted to 
FEBS) 
pREP4 
Accessory plasmid (3740 bp): p15A ori, lacI, neo 
(KanR) 
Qiagen 
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- pBBR1MCS (Fig. 2.1) is a relatively small (4.7 kb) broad-host-range 
plasmid, derived from pBBR1CM (Antoine & Locht, 1992), which confers 
chloramphenicol resistance, has a multiple cloning site (Kovach et al., 1994) 
and is stably maintained as an extrachromosomal element in both E. coli, 
Bordetella bronchiseptica and Brucella species (Elzer et al., 1995). 
 
Figure 2.1. Circular map of plasmid pBBR1MCS. Unique-cutting restriction sites are shown 
in blue together with the position at which they cut. 
 
- pSC-A is a plasmid of 4.3 kb provided with the StrataClone PCR Cloning 
K for high-efficiency ligation and cloning in E. coli StrataClone SoloPack 
cells. The plasmid pSC-A is supplied with two DNA arms, each charged with 
topoisomerase I (from Vaccinia virus) on one end and containing a loxP 
recognition sequence on the other end (Fig. 2.2). The topoisomerase-charged 
ends have a modified uridine (U*) overhang. Taq-amplified PCR products, 
which contain 3´-adenosine overhangs, are efficiently ligated to these vector 
arms in a 5-minute ligation reaction, through A-U* base-pairing followed by 
topoisomerase I-mediated strand ligation. The resulting linear molecule is 
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transformed into competent cells engineered for the expression of Cre 
recombinase from bacteriophage P1. Cre-mediated recombination between 
the vector loxP sites creates a circular DNA molecule (Fig 2.2) that is 
proficient for replication in cells growing on media containing ampicillin 
and/or kanamycin. 
The pSC-A plasmid has two origins of replication, contains genes for 
ampicillin (bla) and the kanamycin (neo) resistance, and allows the 
blue/white selection of clones, since the insertion of the PCR fragment 
interrupts a lacZα cassette. 
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Figure 2.2. pSC-A and Strataclone PCR cloning kit strategy.(Stratagene). 
 
- pET-3a (Fig. 2.3). The pET System is a powerful system for the cloning 
and expression of recombinant proteins in E. coli. Target genes are cloned in 
pET plasmids under control of strong bacteriophage T7 transcription and 
(optionally) translation signals; expression is induced by providing a source 
of T7 RNA polymerase in the host cell, that selectively transcribes target 
genes. Target genes are initially cloned using hosts that do not contain the T7 
RNA polymerase gene, thus eliminating plasmid instability due to the 
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production of proteins potentially toxic to the host cell. Once established in a 
non-expression host (e.g. E. coli DH5α), plasmids are then transferred into 
the expression hosts containing a chromosomal copy of the T7 RNA 
polymerase gene under lacUV5 control (e.g. E. coli BL21(DE3)), and gene 
expression is induced by the addition of isopropyl-β-D-thiogalactoside 
(IPTG), an analogue of lactose. 
- pQE60 (Fig. 2.3) belongs to the pDS family and derived from 
pDS556/RBSII plasmid. It consists of 3429 bp and contains phage T5 
promoter and two lac operators. The regulation of the promoter/operator is 
very efficient: the transcription is blocked in the presence of lac repressor 
(lacI), while it is rapidly induced by the addition of IPTG, which inactivates 
the repressor and makes the promoter accessible. The plasmid has a 
polylinker immediately downstream of a synthetic ribosome binding and 
carries the ampicillin resistance bla gene. Furthermore, it possesses a 
sequence coding for six histidine residues (His tag), which precedes the 
translation termination codons. This accessory protein portion can be used to 
purify the expressed protein, by affinity chromatography on a nickel column, 
which was not the case for GadB and its variants characterised in this work. 
- pREP4 is a 3740 bp plasmid, which contains the lacI gene encoding the lac 
repressor. The presence of this accessory plasmid in the cell carrying pQE60 
or its derivatives provides high levels of repressor, thus increasing the 
efficiency in repressing the lac operator of pQE60. This plasmid contains 
also the kanamycin resistance gene (neo) and an origin of replication (p15A) 
different from that of pQE60, which allows their co-existence in the host. 
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Figure 2.3. Maps of pET-3a and pQE60 plasmids. 
2.2 N-terminal sequence determination of BmGadB 
The low-copy-number plasmid pBBR-gadBC_Bm (Tab. 2.1), carrying a 
3.52 kb genome fragment encompassing the whole B. microti gadBC operon 
under its indigenous promoter, was used to transform the E. coli strain 
CC118 (cfr. 2.3.2).  
Preliminary analysis on the expression and functionality of BmGadB was 
performed. Briefly, a 50-ml culture was grown overnight (i.e. 18 hours) in 
LB broth at 37°C. Bacterial cells were collected by centrifugation at 3500 
rpm, resuspended in 1 ml of an aqueous solution containing 1 mM PLP/1 
mM DTT and disrupted by sonication. The cleared supernatant was subjected 
to western blotting (cfr. 2.6.6) and Gad activity assay (cfr. 2.6.3). As control, 
the E. coli strain CC118 carrying the empty plasmid pBBR1MCS was 
analysed in parallel. 
A 11 μg aliquot of partially purified BmGadB (corresponding to approx. 5 
μg of pure BmGadB) was subjected to SDS-PAGE followed by blotting onto 
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polyvinylidine difluoride (PVDF) membrane (cfr. 2.6.6). The area of the 
PVDF membrane corresponding to BmGadB was excised and subjected to N-
terminal sequencing (Proteome Factory AG, Berlin, Germany). 
2.3  Recombinant DNA techniques 
2.3.1 Purification of plasmid DNA, digestion with restriction 
enzymes and electrophoresis 
The purification of plasmid DNA was performed using the Nucleospin® 
plasmid kit (Macherey-Nagel), which allows the quick isolation of 
supercoiled plasmid with high yields. Briefly: a single colony is inoculated in 
LB medium containing the antibiotic, and the cell culture is incubated at 
37°C with constant shaking (200 rpm) overnight (> 16 h). Cells are harvested 
by centrifugation and the bacterial pellet is resuspended in a buffer solution 
containing RNAasiA 100 µg/ml. Then, an alkaline/SDS lysis is performed for 
few minutes at room temperature and the lysate is neutralized by adding a 
solution containing guanidinium hydrochloride and acetic acid. Precipitated 
protein, genomic DNA, and cell debris are then pelleted by a centrifugation 
step (10 min at 16000 g). The supernatant is loaded onto a NucleoSpin® 
Plasmid column and centrifuged for 1 min at 16000 g. The flow-through is 
discarded and the column is washed with a buffer containing guanidinium 
hydrochloride and isopropanol, followed by centrifugation for 1 min at 16000 
g. An additional washing step is performed with a buffer containing ethanol. 
The centrifugation is repeated to remove residual ethanol and then plasmid 
DNA is eluted in µl 50 H2O or 10 mM Tris/HCl buffer, pH 8.5. 
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The DNA concentration was determined spectrophotometrically, using the 
conversion factor: O.D.260 nm  1.0 = 50 µg/ml. 
Digestions with restriction enzymes were performed according to the 
manufacturer's instructions (Roche). The DNA fragments obtained were 
analysed on agarose gel and their sizes deduced by comparison with 
appropriate molecular weight standard (Fermentas). 
The agarose gel (1% w/v) was prepared in 1X TAE buffer (0.04 M Tris;1 
mM EDTA; 5 mM sodium acetate, adjusted to pH 7.5 with glacial acetic 
acid. Ethidium bromide (0.4 μg/ml), which intercalates into the DNA double 
helix, was added just before pouring the gel. Before loading, 0.2 volumes of 
dye (0.25% (w/v) bromophenol blue; 0.25% (w/v) xylene cyanol; 30% 
glycerol (v/v)) were added to each sample. Electrophoresis was performed at 
70 V for a time ranging from 30 min to 1 h. After the run, the DNA in the gel 
was visualized by UV irradiation at 254 nm (transilluminator). The extraction 
of DNA from agarose gels was performed using Nucleospin® gel and PCR 
clean-up kit (Macherey-Nagel). 
2.3.2  Competent cells: preparation and transformation 
Competent cells of E. coli CC118, DH5-T1R, and BL21(DE3) were 
prepared by inoculating few colonies from an LB plate in 50 ml 2x XL. Cells 
were grown at 37°C to an OD600 of 0.5 and then kept on ice for 90 minutes. 
Following centrifugation at 4000 rpm for 15 minutes, at 4°C, the cell pellet 
was resuspended in 20 ml of buffer containing 100 mM CaCl2; 70 mM 
MnCl2, 40 mM sodium acetate, pH 5.5 and kept in ice for 45 minutes. After a 
further centrifugation at 4000 rpm for 15 minutes, at 4°C, the cells were 
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resuspended in 3 ml of the same buffer containing 80% glycerol. The cells 
were stored at -80°C in aliquots of 220 μl. 
For transformation, 100 μl of competent cells were added to 20-50 ng of 
DNA. The mixture was incubated for: 30 minutes on ice, 4 minutes at 37°C 
(thermal shock) and for 2 minutes on ice. SOC medium (1.05 ml) was added 
and the incubation prolonged for additional 15 minutes at room temperature. 
Cells were grown for 100 minutes at 37°C. An aliquot of the transformation 
(120 μl) was plated on LB agar containing the required antibiotic. 
2.3.3 PCR 
The polymerase chain reaction (PCR) was used for both amplification of 
specific DNA fragments to be cloned (preparative PCR; cfr. 2.4.1) and to 
verify for the presence of the desired DNA fragments after their cloning in 
different vectors (analytical PCR; cfr. 2.4.2 and 2.4.3). The oligonucleotides 
used in this work are listed in Table 2.2. 
 
Table 2.2. Oligonucleotides used in PCR. 
Oligo Sequence 
Br_for2 * 5’-GGCATATGACTGGTTCAAACTATCCG-3’ 
Br_rev * 5’-GGGGATCCTTATGTGTGGTGAAAGCCG-3’ 
TT3 ** 5’-CCTCGAGGTCGACGGTA-3’ 
pET ** 5’-GAAATTAATACGACTCACTATAGGG-3’ 
 
* The italicized sequences indicate the NdeI (for) and BamHI (rev) restriction sites. 
** Oligonucleotides that anneal upstream of the cloning site of pSC-A and pET plasmid 
respectively. 
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2.4 Cloning of BmGadB 
2.4.1  Preparative PCR 
The gadB ORF (i.e. starting from the ATG codon identified by N-terminal 
sequencing) of B. microti was amplified by the FastStart High Fidelity PCR 
system using pBBR-gadBC_Bm (Table 2.1) as template. Oligonucleotides 
Br_for2 and Br_rev (Table 2.2) were designed to anneal over the start and the 
stop codons of the gadB gene respectively and comprise the NdeI and BamHI 
restriction sites sequences, respectively, for subsequent directional cloning 
into the pET-3a expression vector (Novagen; cfr. 2.4.3). 
 
Preparative PCR mixture (50 µl): 
- pBBR-gadBC_Bm   1 μl (5 ng) 
- Br_for2 (25 µM)   0.8 μl (0.4 µM) 
- Br_rev (25 µM)   0.8 μl (0.4 µM) 
- dNTPs (10 mM each)    1 μl (0.2 mM) 
- Buffer 10X High Fidelity (Roche) 5 μl (1X, MgCl2 1.8 mM) 
- Sterile H2O for PCR   40.9 μl 
- FastStart High Fidelity (Roche) 0.5 μl (2.5 U) 
 
PCR reaction: 
1) Hot Start:    95° C for 2 min 
2) Cycle PCR (the cycle is repeated 25 times): 
Denaturation:    95° C for 30 sec 
Annealing:    50° C for 30 sec 
Extension:    72° C for  1 min 30 sec 
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3) Final extension:  72° C for 7 min 
4) Cooling:   8° C for 5 min 
2.4.2  Cloning with Strataclone PCR Cloning Kit 
The PCR product obtained as described in 2.4.1 was analysed on agarose 
gel, extracted from gel (cfr. 2.3.1) and then directly cloned into the pSC-A 
vector of the StrataClone PCR Cloning Kit (cfr. 2.1) to generate the 
recombinant plasmids pSC-A_Bm-gadB (Table 2.1). Ligation and cloning 
were carried out following manufacture’s protocol (Stratagene).  
E. coli StrataClone SoloPack transformants were selected by blue/white 
screening. In order to verify if the selected white colonies resistant to 
ampicillin, contained the plasmid pSC-A_Bm-gadBC, transformants were 
screened for the presence of the insert by colony PCR. Since pSC-A plasmid 
contains a BamHI restriction site, the orientation of the insert is important for 
the next step, i.e. cloning into pET-3a. Thus, colony PCR was performd using 
the following oligonucleotides: TT3, annealing upstream the insertion site of 
the PCR product, and Br_for2 which was used for gadB amplification (Table 
2.2). 
 
Mix for analytical PCR (30 µl): 
A) 10 µl of sterile H2O for PCR in which the colony to be analyzed has been 
previously transferred. 
B) Reaction Mix (20 µl) 
- TT3 (25 µM)   0.6 μl (0.4 µM) 
- Br_for2 (25 µM)  0.6 μl (0.4 µM) 
- dNTPs (10 mM each)  0.6 μl (0.3 mM) 
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- Buffer 10X (GeneSpin) 3 μl (1X, MgCl2 1.5 mM) 
- Taq Pol (GeneSpin)  0.3 μl (1.5 U) 
 
PCR reaction: 
1) Hot Start:    95° C for 2 min 
2) Cycle PCR (the cycle is repeated 30 times): 
Denaturation:   95° C for 30 sec 
Annealing:   50° C for 30 sec 
Extension:   72° C for  1 min 30 sec 
3) Final extension:  72° C for 10 min 
4) Cooling:   8° C for 5 min 
 
Then, plasmid DNA was purified from two out of seven positive clones (cfr. 
2.3.1). The obtained material was analysed using the restriction enzymes 
NdeI and BamHI which were introduced into the PCR product with 
oligonucleotides Br_for2 and Br_rev, respectively (Table 2.2). Both plasmids 
produced the expected fragmentation pattern and were fully sequenced on 
both strands to check for any unwanted mutation. Only one plasmid was 
chosen for the next step of cloning. 
2.4.3  Cloning into pET3a 
Plasmid pSC-A_Bm-gadB was digested with NdeI and BamHI and the 
resulting 1395-bp DNA fragment corresponding to the whole Bm-gadB ORF 
was subcloned into pET3a, previously digested with the same restriction 
enzymes and dephosphorylated at the 5’ end using calf intestinal alkaline 
phosphatase (Roche). 
58 
 
The ligation reactions were carried out using the enzyme T4 DNA ligase 
(Roche). This enzyme promotes the joining of DNA strands which have 5'-
phosphate and 3'-OH ends in a DNA molecule using ATP as a cofactor. The 
reactions were performed according to the manufacturer’s instructions and 
using a vector/insert ratio 1:3. 
The newly generated plasmid pET3a_Bm-gadB was used to transform E. coli 
DH5α competent cells prepared according to standard protocols (Sambrook 
et al., 1989). Transformants were screened for the presence of the insert first 
by colony PCR using the following oligonucleotides: pET, which anneals 
upstream the polycloning site of pET3a, and Br_rev used, for gadB 
amplification (Table 2.2), and then by digestion with NdeI and BamHI 
restriction enzymes. 
 
Mixture for analytical PCR (30 µl): 
A) 10 µl of sterile H2O for PCR in which the colony to be analyzed has been 
previously transferred. 
B) Reaction Mix (20 µl) 
- pET (25 µM)   0.6 μl (0.4 µM) 
- Br_rev (25 µM)  0.6 μl (0.4 µM) 
- dNTPs (10 mM each)  0.6 μl (0.3 mM) 
- Buffer 10X (GeneSpin) 3 μl (1X, MgCl2 1.5 mM) 
- Taq Pol (GeneSpin)  0.3 μl (1.5 U) 
 
PCR reaction: 
1) Hot Start:    95° C for 2 min 
2) Cycle PCR (the cycle is repeated 30 times): 
Denaturation:   95° C for 30 sec 
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Annealing:   55° C for 30 sec 
Extension:   72° C for  1 min 30 sec 
3) Final extension:  72° C for 10 min 
4) Cooling:    8° C for 5 min 
 
Two clones were found to be positive by both PCR analysis and restriction 
analysis. 
For protein purification, the plasmid construct pET3a_Bm-gadB was 
transferred into the expression strain E. coli strain BL21(DE3), a Gad-
negative strain as based on the Rice test (cfr. 2.6.1) and the quantitative Gad 
activity assay (cfr.2.6.3). 
2.5 Expression and purification of EcGadB and BmGadB 
Protein purification of EcGadB (De Biase et al., 1996) is described in this 
section. 
The conditions used for expression and purification of BmGadB from E. 
coli strain BL21(DE3)/pET3a_Bm-gadB were essentially as described for 
wild type EcGadB, except that bacteria were grown in LB broth containing 
glucose 0.5% and chromatography was carried out on a smaller-sized column 
(2.1 cm x 20 cm). 
Expression and purification of EcGadB-D86NH465A from E. coli 
JM109/pREP4/pQgadB-D86NH465A was as described for wild type GadB 
except for the pH of the potassium phosphate buffer used during the DEAE-
Sepharose chromatography, i.e. pH 6.0 instead of 6.5. Furthermore a second 
DEAE-Sepharose chromatography step was performed at pH 6.5, where the 
protein elutes during the washing step.  
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EcGadB-H465A (Pennacchietti et al., 2009) was purified for comparative 
analyses. 
2.5.1 Growth and induction of the bacterial culture 
EcGadB was purified by adopting the protocol described by (De Biase et 
al., 1996). Briefly, some colonies of the E. coli strain JM109/pREP4/pQgadB 
from LB plate are inoculated into liquid medium LB containing ampicillin 
100 mg/ml and kanamycin 25 mg/ml. Bacteria are grown overnight at 37° C 
under agitation (200 rpm). Subsequently, this pre-culture is inoculated 
(1:100) into 2 liters of SB , preheated to 37°C, containing: 
- 50 mM potassium phosphate, pH 7.5; 
- Ampicillin 200 mg/ml; 
- Kanamycin 25 mg/ml; 
- Pyridoxine (vitamin B6) 0.1 mg/ml. 
The growth is carried out at 37° C under aeration. When the culture reaches 
OD600 = 0.7, IPTG is added to a final concentration of 2 mM, to induce the 
expression of the gene inserted into pQE60 vector (or pET3a in the case of 
BmGadB). Growth is carried out until the culture reaches an optical density 
not exceeding 2 (approximately 3 hours). It is important to not prolong the 
growth too much, in order to avoid the expression of endogenous GadA/B 
produced by JM109 in stationary phase. The choice of expressing GadB in 
this strain was also based on the experimental observation that although 
containing active gadA/B genes it does not express the enzyme at significant 
levels even when the culture reaches O.D.600 = 3 (De Biase et al., 1996). At 
the end of growth, cells are collected by centrifugation at 5,000 rpm for 15 
minutes at 4°C. 
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2.5.2  Bacterial lysis, precipitation of nucleic acids and ammonium 
sulphate fractionation 
Bacteria, harvested by centrifugation, are resuspended in a solution 
containing 1 mM PLP and 1 mM DTT, and disrupted by sonication (16,000 
Hz for 10 cycles of 30 seconds each alternating 1 minute in ice). After 
sonication, cell debris is removed by centrifugation at 10,000 rpm for 20 
minutes at 4°C. In order to precipitate nucleic acids, 0.1 volume of a 
streptomycin sulfate 10% (w/v) solution is added to the supernatant after 
centrifugation. The solution is maintained under stirring for 10 minutes at 
room temperature and, then, centrifuged at 10,000 rpm for 20 minutes at 4°C. 
Solid ammonium sulfate was added to the supernatant at a concentration (390 
mg/ml) which corresponds to 60% of saturation. At this percentage of 
saturation most of the proteins precipitate, including GadB. The precipitate, 
recovered by centrifugation at 10,000 rpm for 20 minutes at 4°C, is 
resuspended in few ml of 0.1 M potassium phosphate buffer, pH 6.5, 
containing 0.1 mM DTT. The material is dialyzed overnight at 4°C against 3 
L of the same buffer to remove the ammonium sulfate. 
2.5.3  DEAE-Sepharose chromatography 
The dialyzed material is loaded on a DEAE-Sepharose anion exchange 
column of (30 cm x 2.5 cm diameter), pre-equilibrated with phosphate buffer. 
Chromatography is carried out by applying a gradient of potassium phosphate 
buffer, pH 6.5, containing 0.1 mM DTT, 0.1 M (300 ml ) to 0.5 M (300 ml), 
and collecting the eluate in fractions of about 12 ml. At pH 6.5 the absorption 
maximum of the chromophore at 340 nm and GadB is not visible, therefore 
its presence in each fraction is assayed by measuring the absorbance at 280 
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nm and by enzyme activity assay (cfr. 2.6.3). The purest fractions containing 
GadB are pooled and the protein material precipitated by ammonium sulfate 
at 60 % saturation (390 mg/ml). The precipitate is dissolved in few ml of 0.1 
M sodium acetate/acetic acid buffer, pH 4.6, containing 0.1 mM DTT, and 
dialyzed overnight at 4°C against 3 L of the same buffer. The dialysate is 
centrifuged at 10,000 rpm for 15 minutes to remove conspicuous protein 
precipitate (contaminants, but not GadB) that occurs at acid pH. 
Table 2.3 shows the trend of a typical purification of E. coli GadB from two 
liters of bacterial culture. The enzyme concentration and activity were 
assayed as described in 2.5.4 and 2.6.3. 
The purity of the protein was judged by 12% SDS-PAGE (cfr. 2.6.6, Fig. 2.4) 
 
Table 2.3. Purification of wild type EcGadB. 
 
 
 
 
 
 
 
 
Purification step 
Total 
protein 
(mg) 
Total Units 
(U) 
Specific activity 
(U/mg) 
Clarified lysate 634 32130 50.7 
Streptomycin (Sn) 567 34123 60.2 
60% amm. Sulfate + dialysis 426 32190 75.6 
# DEAE-Sepharose 142 31247 220.0 
Dialysis at pH 4.6 130 29248 225.0 
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Figure 2.4. Purification of wild type E. coli GadB(EcGadB). 12% SDS-PAGE, stained with 
Coomassie Blue. Abbreviations used: NI, total cell extract from not induced cultures; 1h, 2h 
3h, total cell extract after 1 hour, 2 hours or 3 hours of induction with 2 mM IPTG 
respectively; Son, supernatant of clarified cell lysate; Strp, supernatant subjected to 
precipitation with streptomycin 1% (w/v) and centrifugation; AS, dialysate obtained after 
precipitation by ammonium sulphate at 60% saturation and resuspension in a buffer at pH 
6.5; # DEAE, pooled fractions after anion exchange chromatography at pH 6.5; STD, 
molecular weight standard (from the top: 116 kDa, 66 kDa, 45 kDa, 35 kDa and 25 kDa). 
2.5.4  Determination of Gad and cofactor concentration 
The enzyme concentration was calculated by measuring the absorbance of 
the protein at 280 nm (ε280 = 86 x 10
3
 M
-1
 cm
-1
; (Yang & Metzler, 1979)). 
The PLP content of the purified enzymes was determined 
spectrophotometrically after treating GadB or mutants with 0.1 M NaOH. In 
these conditions, the molar absorption coefficient (ε) at 388 nm of the 
released PLP is 6.55 x 10
3
 M
-1
 cm
-1
 (Peterson & Sober, 1954). 
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2.5.5  ApoGadB production 
Recombinant E. coli GadB was purified in the holo form. The apoenzyme 
was prepared by mixing the enzyme (2.7 mg/ml) in 0.2 M pyridine/HCl 
buffer at pH 4.6, containing 0.1 mM DTT, with the substrate analogue α-
methyl-Glu 0.1 M. In the presence of this substrate GadB catalyses an 
abortive transamination (cfr. 1.2.1), a slow side reaction, that leads to the 
formation of a ketoacid and pyridoxamine 5'-phosphate (PMP), with 
consequent inactivation of the enzyme. The reaction was performed o.n. at 
4°C and followed spectrophotometrically (De Biase et al., 1991).  
In order to remove PMP and other contaminants, apoGadB was loaded onto a 
gel filtration PD10 column (GE Healthcare) and eluted in 50 mM HEPPS / 
150 mM NaCl buffer, pH 8.0, containing 0.1 mM DTT. 
2.6 Analytical techniques 
2.6.1 Gad test (Rice test) 
Glutamate decarboxylase activity was qualitatively detected as described 
by Rice et al. (Rice et al., 1993). Gad test allows for rapid detection of Gad 
activity by the observation of the change in color from yellow to blue of the 
pH indicator bromocresol green following pH increase. In this rapid test, the 
hypertonicity of the reagent (9% NaCl) leads to release in the assay solution 
of the intracellular Gad enzyme. This allows the enzyme to react with the 
glutamic acid in the Gad reagent. 
Briefly 2 ml of an overnight culture grown in LB broth are centrifuged (15 
min at 4,000 rpm) and washed twice with an equal volume of physiological 
solution. The pellets are resuspended in 100 μl of Gad reagent (1 g glutamic 
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acid; 90 g NaCl; 3 ml of Triton X-100; 0.05 g of bromocresol green for 1 L 
of distilled water, pH 3.4), resuspended by vigorous vortexing and incubated 
at 37°C up to 1 hour. The test is judged positive if the color of the 
supernatant from yellow turns  blue, indicative of neutralization of the 
reaction solution. 
2.6.2 GABA assay 
The amount of GABA released in bacteria spent medium was measured 
using GABase (Sigma), a commercial preparation consisting of two enzymes, 
GABA-transaminase (GABA-T) and succinic semialdehyde deidrogenase 
(SSA-DH), which sequentially convert GABA into succinic semialdehyde 
(SSA) and succinic acid, with the concomitant reduction of NADP
+
 into 
NADPH + H
+
. The NADPH produced during the reaction is a direct measure 
of GABA present in the sample and it is calculated by reading the absorbance 
at 340 nm (ε340 = 6,220 cm
-1
 M
-1
). 
For E. coli MG1655 (or mutant derivatives), 25-50 μl of supernatant of a 
stationary phase overnight culture grown in LB broth + 0.4% glucose at pH 
5.5 was added to 200 μl of assay solution. This solution consists of: 0.1 M 
HEPPS, pH 8.6; 1 mM NADP
+
 pH 7.0; 1 mM α-ketoglutarate, pH 7.0; 3 mM 
β-mercaptoethanol and 0.03 U of GABase/assay. 
For E. coli CC118, 50 μl of supernatant of a stationary phase overnight 
culture grown in LB broth pH 7.4 was added to 200 μl of assay solution. 
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2.6.3 Gad activity assay 
Gad activity in both cell extracts and purified enzyme samples was 
assayed by measuring GABA production with Gabase as previously 
described (De Biase et al., 1996). 
To assay the decarboxylase activity two tubes are prepared, each containing: 
1) 100 μl of sample (2-10 μl cell lysate/purified enzyme) in pyridine buffer; 
2) 100 μl 100 mM monosodium glutamate in pyridine buffer. 
The pyridine buffer consists in 0.2 M pyridine/HCl at pH 4.4-4.6 containing 
0.1 mM DTT and 1 mM PLP. Both tubes are allowed to equilibrate at 37°C 
for 5 minutes and the content of tube 2 is transferred into tube 1 to start the 
reaction, which is allowed to proceed for 1 or 2 minutes. To halt the reaction 
0.8 ml of 0.1 M HEPPS at pH 8.6 are added and the solution is vigorously 
vortexed. GABA is then quantified using Gabase (cfr. 2.6.2). The 
decarboxylase activity is expressed as U/mg, i.e. μmol of GABA produced 
per minute at 37°C per mg protein (total or purified). 
The cells, harvested from overnight cultures grown in LBG at pH 5 (4,000 
rpm for 15 min at 4°C), were resuspended in 1 ml of a solution containing 1 
mM PLP, 1 mM DTT and protease inhibitors (Complete, Roche). The cells 
were sonicated for 7 cycles (15 seconds ON with 15 seconds OFF). Then the 
cell lysate was centrifuged at 12,000 rpm for 15 minutes at 4°C, to remove 
cells debris. The supernatant was immediately used to assay the protein 
concentration (Bradford assay) and the decarboxylase activity. 
Gad activity of purified BmGadB, EcGadB wild type, H465A and 
D86NH465A mutants (0.2-0.4 µM, referred to the monomer concentration) 
was assayed in pyridine buffer, as described above. Alternatively, reactions 
were performed in 50 mM sodium acetate or potassium phosphate buffers at 
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different pH values, in the presence of 40 µM PLP and in the 
presence/absence of 50 mM NaCl. The protein concentration was 0.5-1.9 
µM. 
GABA production of purified EcGadB wild type, H465A and 
D86NH465A mutants was assayed over a period of 3 hours, at 30°C, in 4 ml 
of 50 mM potassium phosphate buffer, pH 7, in the presence of 40 μM PLP 
and 50 mM sodium glutamate. The protein concentration was 2 μM. At time 
intervals, aliquots (100 μl) of the reaction mixture were withdrawn and 
analyzed for GABA content with the Gabase assay. 
Kinetic constants of EcGadB wild type, H465A and D86NH465A 
mutants (0.038 µM) were determined performing the reaction at 25°C in 500 
µl of 50 mM sodium acetate pH 4.6, in the presence of 40 µM PLP, varying 
glutamate concentration (0.3-80 mM). At time intervals, aliquots (50 μl) of 
the reaction mixture were withdrawn and analyzed for GABA content with 
the Gabase assay. 
2.6.4  Isotope effect 
Analysis of isotope effect assumes that there are differences in kinetic or 
equilibrium properties of isotopically substituted molecules that can be 
measured (Cornish-Bowden, 1995). Two heavy isotopes of hydrogen, 
2
H and 
3
H (deuterium, D and tritium, T), are commonly used for studying isotope 
effect, due to their relative differences in atomic mass, which are at their 
greatest for the lightest elements. Isotope effect concerns both reacting bonds 
and solvent. 
The EcGadB D86NH465A were brought into 99.8% D2O by concentration 
and dilution. The enzyme (0.8 µM) was mixed with glutamate (30 mM). In 
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order to maintain constant pD to 4.6 (reading on pH meter = 4.2) DCl was 
added. The reaction rate was determined by recording the consumption of 
deuteron over time. The reaction was performed also in H2O/HCl (pH 4.6). 
For comparison, EcGadB wild type and H465A mutant were also analysed. 
2.6.5  Protein assays 
The Bradford protein assay method exploits the capacity of the dye 
Coomassie Brillant Blue (G-250) to bind to proteins in a solution and 
generate a colored compound which specifically absorbs at 595 nm in an 
acidic environment (Bradford, 1976). 
A calibration curve is constructed by recording the reading at 595 nm of BSA 
(bovine serum albumin) at known concentration (10-100 μg/5 ml of Bradford 
reagent). The Bradford reagent contains: 0.01% Coomassie Brillant Blue, 
4.7% ethanol, 8.5% phosphoric acid. The sample is assayed following the 
same procedure as used for BSA and its protein concentration interpolated on 
the calibration curve. For reliable measurements of protein concentration, the 
protein sample should always give a reading within the range of the 
calibration curve. 
The Bicinchoninic acid assay (BCA) is a colorimetric assay for the 
quantitation of total protein in the presence of detergents, not compatible with 
Bradford assay. The system exploits the ability of BCA to detect the presence 
of Cu
+1
, which results from reduction of Cu
+2
 by protein, in an alkaline 
environment, according to the following scheme: 
1) protein + Cu
+2
 (colorless) → protein-Cu +1 
2) protein complex-Cu
+1
 +2 BCA → complex BCA-Cu+1 (violet) 
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The purple-colored reaction product is formed by the chelation of two 
molecules of BCA with one Cu
+1
, exhibits absorption maximum at 562 nm. 
The color intensity is nearly linear with increasing protein concentrations. A 
calibration curve is constructed by recording the absorbance at 562 nm of 
BSA at known concentration (1-10 μg/0.5ml) diluted 1:2 with BCA reagent,  
incubated 1h at 60°C and cooled at room temperature. The BCA reagent 
(Thermo Scientific-Pierce) is composed of 25 parts of solution MA (sodium 
carbonate, sodium bicarbonate and sodium tartrate in 0.2 N NaOH), 24 parts 
of solution MB (bicinchoninic acid 4.0 % in water), 1 part of MC solution 
(copper sulfate 4.0 % in water). Protein samples are processed in the same 
manner and unknown protein concentrations are determined using the 
standard curve. 
2.6.6 SDS-PAGE electrophoresis and immunoblot analysis 
SDS-PAGE is a technique used to separate a mixture of proteins according 
to their molecular weight (Laemmli, 1970). The gel consists of an upper part 
(pH 6.8, stacking gel) in which the concentration of acrylamide is 5% (w/v), 
and a “separation” zone (pH 8.8, running gel) in which the percentage of 
acrylamide can be chosen depending on the MW of the protein(s) under 
analysis (typically 10% to 15%). 
Electrophoresis is carried out at 200 V in a buffer containing 1 g/l SDS; 3 g/l 
Tris; 14.4 g/l glycine, pH 8.3. After the run, the gel is stained (0.25% (w/v) of 
Coomassie blue in 10% acetic acid/50% methanol) and then destained (7% 
acetic acid/25% methanol), to remove excess of stain and to visualize the 
proteins as blue bands on a clear background. 
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Samples were typically run on 12% SDS-PAGE and, when necessary, 
directly electroblotted onto polyvinylidene difluoride membranes (PVDF; 
Immobilon-P, Millipore). GadB was detected with a rabbit polyclonal 
antiserum directed against E. coli GadB (De Biase et al., 1999) and 
horseradish peroxidase-labelled secondary antibody provided with the BM 
chemiluminescence western blotting kit (Roche), following manufacturer’s 
instructions. Due to the significant degree of protein identity (73%), BmGadB 
is recognized by the anti-Gad (E. coli). 
2.6.7 Gel filtration chromatography 
Gel filtration chromatography separates molecules according to 
differences in size as they pass through a gel filtration resin packed in a 
column. The resin is a porous matrix in the form of spherical particles 
chemically and physically stabile and inert, filled with buffer. Samples are 
eluted isocratically. Molecules that are larger than the pores, do not enter the 
matrix and are eluted in the void volume, Vo. Molecules with partial access to 
the pores of the matrix diffuse in and out of the pores (sample portioning 
between the mobile and stationary phase) and elute from the column in order 
of decreasing size. Small molecules such as salts that have full access to the 
pores do not separate from each other and usually elute just before one total 
column volume, Vt, of buffer has passed through the column. This technique 
can be applied to group separations (e.g. to remove high or low molecular 
weight contaminants) or high resolution fractionation of biomolecules (e.g. to 
determine molecular weight or separate one or more components). 
Determination of molecular mass of BmGadB. A sample of BmGAD (1 
mg) was loaded onto a Superdex 200 10/300 GL column (GE Healthcare, 
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Life Sciences) on an Äkta Prime FPLC system at 4°C. The mobile phase (50 
mM sodium acetate buffer, pH 4.5, containing 150 mM sodium chloride) for 
the equilibration and elution was pumped at a flow rate of 0.5 ml/min. 
Oligomerization state of EcGadB. Samples of apoGadB (7-8 mg) or 
apoGadB reconstituted with PLP (5-fold the enzyme concentration) 1h at 
4°C, were loaded onto a Superdex 200 10/300 GL column (GE Healthcare, 
Life Sciences) on an Äkta Prime FPLC system at 4°C. The mobile phase 
(flow rate of 0.5 ml/min) for the equilibration and elution consisted of 50 mM 
HEPPS / 150 mM NaCl buffer, pH 8, containing 0.1 mM DTT. The collected 
fractions (0.3 ml/fraction) were analysed spectrophotometrically.  
The Gel Filtration HMW Calibration Kit (GE Healthcare, Life Sciences), 
with the exclusion of thyroglobulin (669 kDa and therefore outside the 
separation range of the column), was used for column calibration and 
molecular weight determination. 
2.6.8 Spectroscopic analysis 
2.6.8.1 Steady-state spectroscopy 
Enzyme absorption spectra and the absorbance changes in the presence of 
L-glutamate were recorded at the indicated temperatures on a Hewlett-
Packard Agilent model 8452 diode array spectrophotometer. 
Curve fitting and statistical analyses were carried out with Scientist 
(Micromath, Salt Lake City, UT) and GraphPad Prism 4.00 (GraphPad 
Software, San Diego, CA). The pH-dependent variations in 420-nm and 340-
nm absorbance (Abs) were analyzed using Hill equation as in Prism, in which 
pK is the pH at the midpoint of the spectroscopic transition and n is the 
number of protons (i.e. Hill coefficient) participating in the  transition. 
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BmGadB kinetic constants. Values for kcat and Km were determined in 100 
mM sodium acetate buffer, pH 4.1, following the changes in absorbance at 
420 nm and 340 nm occurring during the reaction of BmGadB in the presence 
of different concentrations of L-glutamate, as previously reported (De Biase 
et al., 1996, Tramonti et al., 1998). 
2.6.8.2 Fluorescence 
Many proteins and cofactors, absorbing light in the UV and visible, give 
rise to fluorescence emission spectra. Fluorescence is a type of luminescence: 
the property of some molecules, generally characterized by conjugated 
double bonds, to emit light of longer wavelength in response to 
electromagnetic waves absorption. The fluorescence phenomena occurs when 
the radiation is emitted at a rate of 10
-8
 seconds, while, if the emission is 
achieved at a speed in the order of milliseconds, it is called phosphorescence 
(Fig. 2.5; (Lakowicz, 1983)). Indeed, following excitation with 
monochromatic radiation of appropriate wavelength, the electrons of a 
luminescent molecule are brought from a fundamental electronic state So to 
an excited states (S1 or S2; Fig. 2.5). During their stay in the excited state, the 
electrons can undergo internal and intersystem conversion processes, which 
result in the dissipation of the excitation energy through non-radiative 
processes (Stokes shift), resulting in a return to the lowest vibrational level of 
the excited electronic state. Therefore, the return to the fundamental 
electronic state So is realized by the emission of a less energetic radiation, 
which correspond to a longer wavelength, than that absorbed. 
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Figure 2.5. Jablonski diagram. 
 
The fluorescence quantum yield (i.e. the ratio of photons emitted and 
photons absorbed by a molecule, takes into account of the excitation energy 
dissipation factors and also includes two additional phenomena: quenching 
and the energy transfer. Quenching is the term that indicates the decrease in 
the intensity of fluorescence emission that can originate from different 
processes including collisions between the fluorophore and molecules such as 
molecular oxygen or acrylamide, excited-state reactions, complexes  
formation (Lakowicz, 1983). A particular phenomenon of fluorescence 
quenching is the energy transfer. This phenomenon takes place when the 
emission energy of a fluorophore, named donor, is not directly emitted, but is 
transferred to another fluorophore which acts as acceptor. A prerequisite for 
this phenomenon is a large overlap of the donor and acceptor emission 
spectra. Moreover it is necessary that the donor and acceptor are distanced 
less than 80Å and that oriented as electron transfers are allowed. The 
efficiency of energy transfer, which is maximum when the donor emission 
dipole and the acceptor absorption dipole are parallel and minimum when 
they are perpendicular, allows an estimation of the distance between the 
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acceptor and donor providing information about their spatial arrangement 
within a protein. 
The quantum yield of a fluorophore and the centering of its emission peak 
depend on the surroundings in which the molecule is inserted, i.e. the polarity 
of the environment, the degree of solvation and the presence of groups able to 
act as energy transfer acceptors or donors. The amino acid tryptophan, 
excitable at 280 nm, is very sensitive to the environment in which it is located 
and for this reason its ability to emit light is exploited to analyze the 
conformational changes of proteins. 
Fluorescence excitation and emission spectra were obtained with a 
FluoroMax-3 spectrofluorometer (Horiba Jobin-Yvon) equipped with a 
thermostatically controlled cell compartment at 20°C using 5 nm bandwidth 
on both slits (2 nm, when excited at 295 nm) and at a scan speed of 100 
nm/min. The spectra were corrected by subtracting the corresponding buffer 
spectrum. 
2.6.9  Cell fractionation 
Cytoplasmic and membrane fractions from E. coli strain 
BL21(DE3)/pET3a_Bm-gadB were obtained by cell fractionation, essentially 
as described (Capitani et al., 2003). After performing a growth as described 
in section 2.5.1, cell culture was centrifuged at 6000 rpm for 30 min at 4°C. 
The bacterial pellet was initially resuspended in 20 ml of 50 mM Tris/HCl, 
pH 7.0, containing 1 mM DTT and protease inhibitors (Complete, Roche). 
The suspension was then divided into two 10-ml aliquots, and brought to pH 
7.2 and 5.1 by dropwise addition (few µl) of 6 N NaOH or HCl respectively. 
The two samples were then sonicated to disrupt cells and adjusted to the 
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desired pH values (respectively 5.1 and 7.2), where necessary. Cell debris 
and unbroken cells were removed by centrifugation at 5,000 rpm for 20 min 
at 20°C, thus generating the cell supernatants. The cytoplasmic and 
membrane fractions from each cell supernatant were separated via 
ultracentrifugation at 50,000 rpm for 1 h at 20°C. The pellet from 
ultracentrifugation, which represents the membrane fraction, was 
resuspended using 2 ml of 0.1 M Tris/HCl, pH 8.0, containing 150 mM NaCl, 
5 mM EDTA and 0.5 % lauril sarcosine. Total protein content of each sample 
was determined using the detergent-compatible protein assay Micro BCA
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protein assay (Thermo Scientific-Pierce) (2.6.5). The presence of BmGadB 
was analyzed by SDS-PAGE (2.6.6) and Gad activity assay (2.6.3). 
2.7  Crystallization and structural analysis of the apo form of 
EcGadB 
Crystallization experiments and structural analysis were performed at the 
Paul Scherrer Institute (PSI) in Villigen (Switzerland) under the guidance of 
Dr. Guido Capitani and with the technical support of Dr. May Marsh and Dr. 
Florian Dworkowski. 
2.7.1  Protein crystallization 
Dimeric apoGadB at 8.9 mg/ml, in a solution containing 50 mM Hepes 
buffer, pH 8, 0.1 mM DTT, was crystallized at 293 K using the vapor 
diffusion sitting drop method. A drop composed of a mixture of protein and 
precipitant solutions is placed on a shelf in a sealed chamber, in vapor 
equilibration with a reservoir solution of higher precipitant concentration 
(e.g. salts and organic polyalcohols) (Rupp, 2009). The slow diffusion of 
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water vapor from the drop into the reservoir causes both precipitant and 
protein concentration to increase. The protein solution slowly reaches a 
supersaturation level, where nucleation and initial crystal growth occur. 
Afterwards, the solution depletes in protein and a few of the initial crystals 
continue to grow in the growth region of the crystallization diagram once the 
crystals are in equilibrium with the saturated protein solution. This method is 
easily automated: drops are set up once in 96 well plates using a robotic 
dispencer provided with syringe needles suitable for volumes down to about 
100 nl. Plates are sealed with adhesive tape. 
Several crystallization trials were set up in pre-prepared 96-well MRC2 
plates (Hampton Research) using a Mosquito nanolitre pipetting robot (TTP 
Labtech): 100 or 200 nl of the protein solution was mixed with 100 nl of 
different reservoir solutions containing commonly used precipitants; the 
reservoir well contained 50 µl of the screen solution. The screening solutions 
used for the experiments were: Clear Strategy Screen I and Clear Strategy 
Screen II from Molecular Dimension; JCSG + Suite from Qiagen. 
The 96-well plates were sealed, stored and automatically imaged at 20°C 
using a Rock Imager 1000 (Formulatrix, USA). Crystal growth was followed 
for several weeks using either optical microscopy (Leica MZ16 
stereomicroscope) or a web interface that allows users to access and score 
digital images of their own experiments, collected at time intervals. 
A microseeding experiment was also performed in order to obtain larger 
single crystals. In fact, ideal conditions for nucleation and growth differ, i.e. 
higher supersaturation for nucleation than for growth. Microseeding methods 
involve transferring a number of very small nuclei (crushed crystals) in a less 
supersaturated solution for continued growth. 
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Seed preparations were carried out using the ‘seed-bead’ method: crystals 
obtained from initial screens were placed in 50 µl of their respective reservoir 
solution, crushed manually using crystallisation microtools (Hampton 
Research) and then mechanically homogenized on a laboratory vortex 
(D'Arcy et al., 2007). These seed stocks were stored at 193 K. Automated 
seeding was performed in a 96 well plate using the Mosquito robot: 200 nl of 
the protein solution of dimeric apoGadB (5.1 mg/ml) was mixed with 50 nl 
of the corresponding seeds stock and 150 nl of each crystallization solution 
(Clear Strategy Screen I). 
Crystals grew to their full size within 40 days. 
2.7.2  X-ray Diffraction Experiment 
In a typical X-ray diffraction experiment, a single crystal of the molecule 
of interest is placed into a finely focused X-ray beam, and diffraction images 
are recorded. The electron density representing the atomic structure of the 
molecules in the crystal is reconstructed by Fourier methods from diffraction 
data and an atomic model of the structure is built into the electron density, 
and refined (Rupp, 2009). The Fourier reconstruction from reciprocal 
diffraction space back to direct molecular space requires two terms, as 
Fourier coefficients: the structural factor amplitudes (accessible in the form 
of square root of the measured and corrected spot intensities) and the phase 
angle. The absence of directly accessible phases constitutes the phase 
problem. To obtain the phases for each reflection, two different approaches 
exist: molecular replacement and experimental phasing (i.e. multiple 
isomorphous replacement and anomalous scattering). Molecular replacement 
method exploits a structurally similar available model to calculate initial 
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phases, which are applied in the initial reconstruction of the electron density.  
Specifically, the calculated Patterson function (the Fourier transform of the 
intensities) of the model molecule is oriented and translated over the 
Patterson function of the unknown structure, to find the correct position of 
the search molecule in the crystal. 
In practice, crystals (10 to a few hundred µm) are harvested under a 
microscope and a single crystal is scooped out of the mother liquor (fishing) 
with a loop or other micro-device and mounted on the goniostat of a 
diffractometer for data collection (Blow, 2002). To prevent damage from 
exposure to X-ray radiation the crystals undergoes to cryocooling to liquid 
nitrogen temperature, sometimes increasing resolution (Pflugrath, 2004). To 
prevent crystalline ice formation during the rapid cooling, cryoprotectants 
(such as glycerol, ethylene glycol, MPD, sucrose and low molecular PEGs) 
are used. Once the data are collected all subsequent steps are conducted in 
silico. 
Single crystals (25-30 µm) of dimeric apoGadB were fished and treated 
with cryo-protection solution containing a 4:1 (or 5:1) mixture of well-
solution and ethylene glycol prior to freezing in a N2 gas stream (flash 
cooling). Diffraction data to 3 Å were collected at 100 K at the PXII 
beamline of the Swiss Light Source using X-ray wavelength of 1 Å. Data 
were processed with XDS. For structure solution we employed molecular 
replacement using available GadB structures (Capitani et al., 2003, Gut et al., 
2006) as a model. 
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2.8  Data Analysis 
Sequence alignment was performed with Clustal Omega 
(http://www.ebi.ac.uk/Tools/msa/clustalo/). Secondary structure predictions 
were obtained using external resources accessible from Expasy 
(http://expasy.org/proteomics). 
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Results and Discussion 
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3.1 PART I: Biochemical and spectroscopic properties of 
recombinant glutamate decarboxylase from Brucella microti 
Background: Genome analysis indicated that the recently described 
Brucella microti CCM4915, an environment-borne pathogenic Brucella 
species isolated from common vole (Scholz et al., 2008), red fox (Scholz et 
al., 2009) and soil (Scholz et al., 2008), contains intact gadB (BMI_II334) 
and gadC (BMI_II335) genes (Audic et al., 2009). On the contrary, in the 
classical species of Brucella, i.e. B. melitensis, B. abortus, B. suis B. canis, B. 
ovis, and B. neotomae, gadB and/or gadC genes are inactivated by stop 
codons and/or frameshift mutations (Tab. 3.1, (Audic et al., 2009)).  
 
Table 3.1. Differences in gadB and gadC genes between B. microti and other Brucella 
species. 
B. microti  ID
Status in B. 
microti
B. suis  I330 
ID
status in 
B.suis  I330
status in 
B.ovis  ATCC 
25840
status in 
B.suis  ATCC 
23445
status in B . 
abortus S19 
status  in B. 
melitensis 
biovar 
Abortus 2308
status in B. 
abortus 
biovar I str. 9-
94I
status in 
B.melitensis 
I6M
status in B. 
canis  ATCC 
23365
status in O. 
anthropi 
ATCC 49I88
Annotation/co
mment
BMI_II334  + BRA0338 *
+ (diff. At the 
beg.)
+ *(2) *(2) *(2) * * NF
glutamate 
decarboxylase 
BMI_II335  + BRA0339 fs fs fs + + + + fs NF
glutamate/ 
gamma-
aminobutyrate 
antiporter 
BMi_II334 ortholog is pseudogene BRA0338, BMI_II335 ortholog is pseudogene BRA0339
Abbreviations include: *for internal stop, anumber indicates multiple stops, fs for frameshift, + for an intact sequence, NF for not found.
Glutamate metabolism
 
(Adapted from (Audic et al., 2009)) 
 
Brucella is a genus of Gram-negative facultative intracellular coccobacilli, 
belonging to the class α-Proteobacteria, that are highly pathogenic for a 
variety of mammals, not host specific but with different host preference. 
Humans, though not primary hosts, can become infected (human brucellosis 
is also known as Malta fever) essentially by the oral route, i.e. by ingestion of 
non-pasteurized milk and dairy products, and also via respiratory and 
conjunctival routes. Recently the World Health Organization (WHO) cited 
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brucellosis as the world's most widespread zoonosis (Franco et al., 2007). Up 
to now, the potential pathogenicity of B. microti for livestock and humans 
remains unknown (Jimenez de Bagues et al., 2010). Nevertheless, this new 
species is not only faster growing and more resistant to an acid stress respect 
to the classical Brucella species, but also lethal in the mouse model. 
The involvement of B. microti gadB and gadC genes in GDAR was 
recently investigated in light of their possible involvement in acid survival 
within the host (Occhialini et al., 2012): both genes were shown to play an 
essential role in GDAR in vitro and to contribute to survival of this 
microorganism in a murine model following oral infection. In addition, the 
acid sensitive strain B. suis 1330 became acid resistant in the presence of Glu 
when complemented with the B. microti gadBC operon carried by a low-
copy-number plasmid (Occhialini et al., 2012). This finding suggested that 
gadB and gadC are necessary and sufficient to complement for the missing 
GDAR phenotype in B. suis. 
Unlike E. coli, the B. microti genome contains only one copy of the Gad 
encoding gene, namely gadB. Its protein product shares 73% sequence 
identity with E. coli GadB (henceforth EcGadB), which is by no doubt the 
most extensively characterised bacterial Gad (De Biase & Pennacchietti, 
2012). As mentioned in the Introduction (cfr. 1.2.3) the homologs of 
EcGadB, including GadB from B. microti (henceforth BmGadB), share a set 
of strictly conserved residues, which are known to occupy critical positions, 
i.e. near the active site or at sites where the conformational changes occur 
(De Biase & Pennacchietti, 2012). Amongst the conserved residues there is 
His465 which is responsible for the reversible inactivation of the enzyme, 
locking the active site at pH > 5.3 (or pH > 5.7 in the presence of chloride 
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ions) via formation of a substituted aldamine (Gut et al., 2006, Pennacchietti 
et al., 2009) (cfr. 1.1.3.2 and 1.2.2). 
To date there are no reports on an in-depth functional, biochemical and 
spectroscopic characterization of Gad from bacterial species other than E. 
coli. One of the aims of the present work was to fill this lack of knowledge as 
well as to investigate whether the pH-dependent molecular mechanisms 
controlling the intracellular activation of EcGadB are also conserved in other 
bacterial Gads, such as BmGadB. Therefore, recombinant BmGadB was 
overexpressed in the laboratory strain E. coli BL21 and the biochemical 
properties of the purified enzyme were compared with those of the 
thoroughly characterized E. coli counterpart. 
3.1.1 Effect of the heterologous expression of B. microti gadBC in 
an E. coli acid-sensitive mutant strain 
Preliminary data. A recent work, published by our group in collaboration 
with Dr. A. Occhialini in Montpellier (Occhialini et al., 2012), showed that a 
3.5 kb genomic region of B. microti encompassing the gadBC operon can be 
functionally expressed in two acid-sensitive mutant strains of E. coli, 
restoring the GDAR phenotype. Specifically, the low-copy-number plasmid 
(pBBR1MCS, hereafter pBBR) carrying the gadBC operon from B. microti 
(pBBR-gadBC_Bm) was introduced into the E. coli MG1655 ΔgadA/ΔgadB 
and ΔgadC strains, that are devoid of Gad activity and acid pH-dependent 
Glu/GABA antiport activity, respectively. In both mutants GDAR was 
restored by heterologous complementation, confirming that gadB and gadC 
of B. microti are functionally expressed in E. coli (Occhialini et al., 2012). 
Furthermore, GABA was absent from the supernatant of the acid-sensitive E. 
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coli ΔgadAΔgadB strain, whereas the wild-type strain and the mutant strains 
complemented with gadBC_Ec or gadBC_Bm exported comparable levels of 
GABA (Occhialini et al., 2012). These findings provided the first strong 
evidence that the only source of GABA in E. coli is Gad. 
When the ΔgadC mutant strain complemented with pBBR-gadBC_Bm was 
assayed for both GABA export and Gad activity, the relative levels were 
found to increase (i.e. almost doubled) respect to the mutant strain, though 
never attained those detected in the mutant strain transformed with the gadBC 
operon from E. coli (pBBR-gadBC_Ec; data reported in D. Bastianelli Ph.D. 
Thesis, 2012). Immunoblot analysis with crude lysates obtained from 
stationary phase cultures of E. coli grown under fermentative conditions, 
confirmed that expression of the GadB protein directed by the gadBC_Bm is 
much less abundant than that observed when GadB was expressed from 
plasmid pBBR-gadBC_Ec. 
To further investigate on the effect of the expression of the gadBC_Bm in 
E. coli, it was necessary to construct the triple mutant 
MG1655ΔgadAΔgadBC in which both the endogenous glutamate 
decarboxylase and antiporter activities were abolished. Therefore the triple 
mutant has the most suitable genetic background for assaying decarboxylase 
and Glu/GABA antiport activities of B. microti GadB and GadC, 
respectively, i.e. no interference from the E. coli gene products. In fact the 
double mutant MG1655ΔgadAΔgadB and the single mutant MG1655ΔgadC, 
initially used for the functional analysis of gadBC_Bm (Occhialini et al., 
2012), still possessed functional gadC and gadA/gadB genes, respectively, 
and therefore still expressing the endogenous antiporter and decarboxylase 
activities. 
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Part of the following data were also reported in the PhD thesis (2012) of 
Daniela Bastianelli ,with whom I shared some of this preliminary work. 
After construction of the triple mutant (described in D. Bastianelli Ph.D. 
thesis, 2012), pBBR-gadBC_Ec and pBBR-gadBC_Bm were used to 
transform it. In order to assess if gadBC_Bm complements the Gad negative 
phenotype of the E. coli triple mutant, a Gad test (i.e. Rice test) was initially 
performed on cell pellets from the relevant cultures (Fig. 3.1C). As controls, 
the wild type E. coli strain MG1655 (positive control) and its isogenic 
derivatives MG1655ΔgadAΔgadB and MG1655ΔgadAΔgadBC strain 
carrying the empty plasmid pBBR (negative control) were included. As 
expected the triple mutant strain carrying gadBC_Bm was found to be 
positive at the Gad test. 
With the purpose of evaluating whether gadBC_Bm is capable to restore the 
GDAR phenotype of triple mutant E. coli strain, the same strains analysed by 
SDS-PAGE and immunoblot analysis were subjected to GDAR assay. 
Briefly, bacteria were grown for ≥ 22 hours in LB broth (pH 5) supplemented 
with 0.4% glucose and diluted 1:1000 in minimal medium EG either in the 
presence or in the absence of 1.5 mM glutamate. Following static incubation 
for 2 hours at 37°C, each sample is diluted and plated on LB plates and the 
percentage of survival determined, using as reference the culture immediately 
after dilution. Data in Fig. 3.1C show that the acid sensitive phenotype of 
MG1655ΔgadAΔgadBC strain is fully reverted into acid resistant in the strain 
complemented with the gadBC_Bm indicating that gadB and gadC genes are 
indeed functionally expressed in E. coli. Despite the recovery of GDAR, the 
gadBC_Bm complemented strain exhibits low level of GABA in the spent 
medium as compared with both wild type and gadBC_Ec complemented 
strain (Fig. 3.1C). 
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A
B
wt AB ABC (B) (E)       GadB(E)
kDa
116
45
66
35
25
18
C
Strain Gad test % Survival GABA (mM) Gad (U/mg)
wt/pBBR + 86 ± 14 0,74 ± 0,39 1,04 ± 0,04
wtΔgadA ΔgadB /pBBR - <1 0 0,07 ± 0,03
wtΔgadA ΔgadBC /pBBR - 0 0 0,062 ± 0,002
wtΔgadA ΔgadBC /pBBR-gadBC_Bm + 76 ± 27 0,28 ± 0,14 0,63 ± 0,04
wtΔgadA ΔgadBC /pBBR-gadBC_Ec + 70 ± 24 3,17 ± 0,21 5,47 ± 0,12  
Figure 3.1. Effects of B. microti gadBC in E. coli triple mutant.The strains used are: 
MG1655/pBBR [wt]; MG1655ΔgadAΔgadB/pBBR [ΔAB]; MG1655ΔgadAΔgadBC/pBBR 
[ΔABC]; MG1655ΔgadAΔgadBC/pBBR-gadBC_Bm [Δ(B)]; MG1655ΔgadAΔgadBC 
/pBBR-gadBC_Ec [Δ(E)]. (A) SDS-PAGE of bacterial lysates (40 µg each) of the strains 
grown to the stationary phase in LBG, pH 5.0. Purified GadB from E. coli [GadB(E), 0.5 μg] 
is included as control (lane 6). (B) Western blot analysis with an anti-EcGadB rabbit 
polyclonal antiserum. The region of the blot shown corresponds to the area indicated by the 
black bar in (A). The quantity of Δ(E) and GadB(E) samples were halved for blotting 
analysis. Molecular weights of protein standards are indicated on the right. (C) Properties of 
the strains in A in terms of i) % survival at pH 2.5 in minimal medium EG + 1.5 mM Glu (2 
h); ii) Gad test (+, positive result, -, negative result); iii) Gad activity (U/mg) and iv) GABA 
export (mM). Abbreviations: E. coli MG1655 (wt). 
The total protein content of each sample was assayed by the method of Bradford. 
 
BmGadB was assayed for activity (Fig 3.1C) and detected by immunoblot 
analysis with anti-EcGadB polyclonal antiserum (Fig 3.1AB) using crude cell 
lysates obtained from the same cultures of the strains assayed for GDAR and 
GABA export (Fig. 3.1C). The levels of GadB activity (Fig 3.1C) in the 
complemented strain reflects the intensity of the signal observed in the 
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western blot (Fig 3.1B), i.e. the activity gadBC_Bm complemented strain is 
approximately 8 times lower than that assayed in the gadBC_Ec 
complemented strain. 
Gad activity and GABA export were also assayed in crude lysates obtained 
from stationary-phase culture of MG1655ΔgadAΔgadBC/pBBRgadBC_Bm 
grown at 37°C in two different media: LBG, i.e. LB pH 5.0 containing 0.4%, 
and LB, pH 7.4 (Tab. 3.2). For comparison, the same strain containing empty 
pBBR was tested. Notably, Gad activity from cells grown in LB is twice as 
high as those grown in LBG, whereas GABA in  the spent medium is 
practically nil in spent LB medium but almost 2 mM in the spent LBG 
medium. The basal level of Gad activity detected in the triple mutant strain 
carrying the empty plasmid is not unexpected. In fact the assay we use 
consists in the measurement of GABA production (rather than CO2 release), 
but this compound can also be present in the cell extract, though at very low 
levels, because it can originate from the reverse reaction carried out by the 
endogenous activities of GABA-transaminase and succinic semyaldehyde 
dehydrogenase. 
 
Table 3.2. Gad activity and GABA export under different growth conditions. 
Strain / condition GABA (mM) Gad (U/O.D.600)
LB pH 7.4
wtΔgadA ΔgadBC /pBBR 0,016 ± 0,001 1,07 ± 0,05
wtΔgadA ΔgadBC /pBBR-gadBC_Bm 0 32,87 ± 1,04
LBG pH 5.0
wtΔgadA ΔgadBC /pBBR 0,050 ± 0,004 0,98 ± 0,71
wtΔgadA ΔgadBC /pBBR-gadBC_Bm 1,97 ± 0,06 15,36 ± 2,45  
 
The results provided in this section indicate that the gadBC operon of B. 
microti is capable of restoring GDAR in an acid sensitive E. coli strain which 
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was constructed to be devoid of Gad and Glu/GABA activities, required to 
fully develop GDAR. Moreover the protein product of the gadB and gadC 
genes were shown to be functional because GAD activity and GABA export, 
undetectable in the E. coli triple mutant strain, were indeed detected in the 
strain complemented with gadBC_Bm. Interestingly, although there is a total 
recovery of GDAR, both the concentration of exported GABA during 
overnight growth in LBG and the Gad activity of the lysates never attain the 
values obtained when the triple mutant was complemented with the E. coli 
gadBC operon (Fig. 3.1).  
3.1.2  Expression and purification of recombinant BmGadB 
The amino acid sequences of BmGadB provided in different databases, i.e. 
NCBI and Patric (Gillespie et al., 2011), differ in the N-terminal region (Fig. 
3.3). In the NCBI Reference Sequence (YP_003105130.1) BmGadB is 
reported to have 6 extra amino acids at the N-terminal end respect to 
EcGadB, whereas in the Patric database the sequence is 2 residues shorter 
than EcGadB. In order to validate experimentally the correct translation 
initiation site among those reported in the different databases, the N-terminal 
amino acid sequence was determined on a partially purified BmGadB 
overproduced in the E. coli CC118 strain transformed with plasmid pBBR-
gadBC_Bm, i.e. carrying the whole B. microti gadBC operon under its 
indigenous promoter (Occhialini et al., 2012). CC118 strain is suitable for 
BmGadB expression because it displays very low level of Gad, as assayed by 
Rice test. Furthermore, Gad activity performed on crude lysates of CC118 
from an overnight culture grown at 37°C in LB medium (1.2 ± 1.2  
U/O.D.600) was more than 15 folds lower than that detected in a common E. 
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coli strain used for cloning and plasmid propagation, i.e. E. coli DH5α (17 ± 
2.8 U/O.D.600). 
The expression and functionality of BmGadB were assessed as described 
in Material and Methods (cfr. 2.2). Gad activity in cell lysate obtained from a 
50 ml stationary-phase culture was 21.2 ± 2.7 U/O.D.600 (at least 10 folds 
higher than in E. coli CC118 strain carrying the empty plasmid pBBR), and 
Gad protein was detected by immunoblot analysis only in CC118 carrying 
pBBR-gadBC_Bm (data not shown). Using the same protocol described for 
EcGadB (cfr. 2.5), BmGadB was purified from E. coli CC118/pBBR-
gadBC_Bm to approx. 50% purity, as estimated by SDS-PAGE (Fig. 3.2). 
1        2
kDa
116
45
66
35
25
 
Figure 3.2. SDS-PAGE of partially purified BmGadB, used for electroblotting. Lane 1, 
partially purified BmGadB (10 μg); lane 2,  EcGadB (1 μg). The molecular mass of protein 
standards is indicated on the right. 
 
Following electroblotting onto PVDF membrane, the protein band 
corresponding to 5 μg (94 pmoles) of BmGadB was subjected to N-terminal 
sequencing by Edman degradation (Proteome Factory, Germany). The 
resulting sequence, Met-Thr-Gly-Ser-Asn, confirmed that the correct N-
terminal sequence is that provided in the Patric database. Thus the sequence 
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of BmGadB consists of 464 amino acids, i.e. it is two amino acids shorter at 
the N-terminal end respect to the EcGadB, with a calculated molecular 
weight of 52,184 Da (Fig. 3.3). 
 
E. coli     ------MDKKQVTDLRSELLDSRFGAKSISTIAESKRFPLHEMRDDVAFQIINDELYLDG  54 
B. microti  MKITLEVIMTGSNYPARDLIASVFGTEALQEIAASRGFPEKEMQANAVYQIIHDELFLDG  52 
                  :  .  .    :*: * **::::. ** *: ** :**: :..:***.***:*** 
 
E. coli     NARQNLATFCQTWDDENVHKLMDLSINKNWIDKEEYPQSAAIDLRCVNMVADLWHAPAPK 114 
B. microti  NARQNLATFCQTWDDDYVHKLMDLSINKNWIDKEEYPQSAAIDLRCVNMVADLWNAPKFA 112 
            ***************: *************************************.**    
 
E. coli     NGQAVGTNTIGSSEACMLGGMAMKWRWRKRMEAAGKPTDKPNLVCGPVQICWHKFARYWD 174 
B. microti  -DNATGTNTIGSSEACMLGGMAMKWRWRKKMQEMGKPTDKPNFVCGPVQVCWHKFARYWD 171 
              :*.************************:*:  ********:******:********** 
 
E. coli     VELREIPMRPGQLFMDPKRMIEACDENTIGVVPTFGVTYTGNYEFPQPLHDALDKFQADT 234 
B. microti  VEIREIPMEPGRLFMGPEQMLEAVDENTIGVVPTFGVTYTGNYEFPEPLQDALDKLQKTK 231 
            **:*****.**:*** *::*:** **********************:**:*****:*  . 
 
E. coli     GIDIDMHIDAASGGFLAPFVAPDIVWDFRLPRVKSISASGHKFGLAPLGCGWVIWRDEEA 294 
B. microti  GLDIDIHVDAASGGFLAPFCAPDIPWDFRLPRVKSISASGHKYGLAPLGCGWVVWRDKEA 291 
            *:***:*:*********** **** *****************:**********:***:** 
 
E. coli     LPQELVFNVDYLGGQIGTFAINFSRPAGQVIAQYYEFLRLGREGYTKVQNASYQVAAYLA 354 
B. microti  LPEELIFNVDYLGGQVGTFAINFSRPAGQVISQYYEFMRLGREGYTKVQQAAYRVAQYIA 351 
            **:**:*********:***************:*****:***********:*:*:** *:* 
 
E. coli     DEIAKLGPYEFICTGRPDEGIPAVCFKLKDGEDPGYTLYDLSERLRLRGWQVPAFTLGGE 414 
B. microti  REIEPLGPYEFICAGEEKGGIPAVCFRIREGEDPGYSLYDLSERLRLTGWQVPAFALSGK 411 
             **  ********:*. . *******::::******:********** *******:*.*: 
 
E. coli     ATDIVVMRIMCRRGFEMDFAELLLEDYKASLKYLSDHPKLQGIAQ-QNSFKHT 466 
B. microt   ASDITVMRVMCRRGFEMDLAALFIRDFKAGIEFFKSHPSPKITPSMGTGFHHT 464 
            *:**.***:*********:* *::.*:**.::::..**. :   .  ..*:** 
 
Figure 3.3. Clustal Omega (version 1.2.0) alignment of EcGadB and BmGadB. The residues 
in bold in BmGadB correspond to the N-terminal sequence experimentally determined by 
Edman degradation and which the indicated numbering is based on. The first 8 amino acids 
(with waved underlining) in BmGadB are those present in the NCBI Reference Sequence 
(YP_003105130.1). The amino acid residues corresponding to the regions undergoing the 
most prominent conformational changes in EcGadB are underlined. The residues 
participating in chloride binding are in a gray background. 
 
Following the identification of the correct ORF in BmGadB, plasmid 
pET3a_Bm-gadB was constructed using the cloning strategy described in 
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(cfr. 2.4). The choice of E. coli BL21(DE3) as host strain for GadB 
expression was based on the consideration that it is a commonly employed 
pET system expression host and, more importantly, exhibits undetectable 
levels of endogenous Gad activity. In fact BL21(DE3) was negative to  the 
qualitative Gad test (cfr 2.6.1). Furthermore, from bacteria grown, harvested 
and sonicated as described for BmGadB purification (cfr. 2.5), Gad activity 
assay gave a 2.8 ± 0.4 U/Liter of culture, i.e. 0.15% of the minimum activity 
assayed in BL21(DE3)/pET3a_Bm-gadB lysates which yielded approx. 1900 
U/Liter of culture. The Gad-negative phenotype of BL21(DE3) might arise 
from mutations in the promoter regions of the gadA and gadB genes or the 
transcriptional regulators of GDAR, as the publicly available genome 
sequence of E. coli BL21(DE3) indicates that both gad genes are present and 
intact. 
Purification of BmGadB was carried out following the protocol used for 
EcGadB (De Biase et al., 1996), with minor modifications (cfr. 2.5), and 
yielded approximately 10 mg from a 2-Liter bacterial culture. The purity of 
the protein was judged to be 95%, as based on SDS-PAGE analysis (Fig. 
3.4), in agreement with the holoenzyme content (i.e. > 95% of total protein 
concentration) assessed by calculating the PLP concentration. Based on these 
data we conclude that BmGadB is purified with the full complement of PLP. 
Under the standard assay conditions used for EcGadB (50 mM sodium 
glutamate in 0.2 M pyridine/HCl buffer, pH 4.4, containing 0.1 mM PLP, at 
37°C), the specific activity of BmGadB was 190 units/mg, a value close to 
that of the E. coli counterpart. 
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Figure 3.4. Purification of recombinant BmGadB. 12% SDS-PAGE, stained with 
Coomassie Blue. Abbreviations used: NI, total cell extract from uninduced cultures; 3h, total 
cell extract after 3 hours of induction with 2 mM IPTG; Son, supernatant of cell lysate 
clarified by low-speed centrifugation; Strp, supernatant after precipitation with streptomycin 
1% (w/v) and centrifugation; AS, dialysate obtained after precipitation with ammonium 
sulphate at 60% saturation and resuspension in a buffer at pH 6.5; # DEAE, pooled fractions 
after anion exchange chromatography at pH 6.5; purified GadB is boiled for 5 min (a) or not 
(b) before loading; STD, molecular mass standard. 
 
The kcat and Km values calculated for BmGadB are provided in Table 3.3. 
Compared to that of wild type E. coli GadB, the Km of BmGadB is 
comparable, while kcat is twice as high, thus resulting in an enzyme with a 
higher specificity constant (kcat/Km). 
 
Table 3.3. Kinetic parameters of BmGadB compared to E. coli GadB. 
GadB 
kcat 
(s
-1
) 
Km 
(mM) 
kcat / Km 
(s
-1
mM
-1
) 
BmGadB 43.63 ± 0.39 1.72 ± 0.07 25.44 ± 1.30 
EcGadB* 24.85 ± 0.13 2.32 ± 0.05 10.71 ± 0.02 
 
The values reported were calculated using the integrated Michaelis-Menten equation to fit 
the curves of the disappearance of the enzyme-substrate complex as a function of time as 
described by (Tramonti et al., 1998). * Data from (Pennacchietti et al., 2009) 
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The purified recombinant BmGadB has an apparent molecular mass of 52 
kDa (based on SDS-PAGE) and migrates as a 307.4-kDa species in FPLC gel 
filtration on a Superdex 200 10/300 GL column (Fig. 3.5). These results 
indicate that at acidic pH, i.e. when the enzyme is maximally active (cfr. 
3.1.3), BmGadB exists as a hexamer like EcGadB. 
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Figure 3.5. Determination of molecular mass of BmGadB. Gel filtration chromatography of 
BmGadB on a Superdex 200 10/300 GL (GE Healthcare) column was carried out in 50 mM 
sodium acetate buffer, pH 4.5, containing 150 mM NaCl, at a flow rate of 0.5 ml/min. HMW 
Calibration Kit (GE Healthcare) included ferritin (440 kDa; a), aldolase (158 kDa; b), 
conalbumin (75 kDa; c), ovalbumin (44 kDa; d). 1 mg of BmGadB was loaded on the column 
immediately after calibration. 
3.1.3  pH-dependent absorbance and activity changes 
BmGadB undergoes distinct pH-dependent spectroscopic changes in the 
absorption spectrum of the cofactor (Fig. 3.6A), just like the E. coli 
counterpart (Pennacchietti et al., 2009) (cfr. 1.2.2). The buffer systems used 
were the followings: 50 mM acetate buffer, in the pH range 3.8-5.8, and 
phosphate buffer in the pH range 6.0-7.0. The absorption spectra of BmGadB 
indicate that the shift of cofactor absorbance from 420 nm to 340 nm occurs 
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upon changing the pH from 4.4 to 5.2, with a clear isosbestic point at 361 
nm. The change in the absorption spectrum corresponds to the conversion 
from the active form of the internal aldimine (i.e. the ketoenamine), which 
absorbs maximally at 420 nm, to the inactive form (i.e. substituted aldamine, 
as confirmed by fluorescence spectra, see Fig. 3.8), which absorbs maximally 
at 340 nm (O'Leary & Brummund, 1974, Gut et al., 2006, Pennacchietti et 
al., 2009). 
The titration curve (Fig. 3.6B) generated by plotting the 420-nm absorbance 
(or the 340-nm absorbance; data not shown) versus pH exhibits a sigmoidal 
dependence and fits well to the Hill equation. The best-fit values returned for 
n (number of protons) and pK (midpoint) of the spectroscopic transition are 
given in Table 3.4. Compared to EcGadB (Pennacchietti et al., 2009), the pH-
dependent spectroscopic transition occurs in a more acidic range (pK = 4.9) 
and is complete at pH 5.2 (Fig. 3.6B). In other words, the 420-nm absorbing 
species is practically undetectable at pH > 5.4 (Fig. 3.6). This latter 
observation point out to an efficient locking of the active site in BmGadB, a 
finding that is also substantiated by the activity assays at pH > 5.4 (see 
below). 
Chloride ions were reported to bind to EcGadB underneath the triple 
helical bundles formed at acidic pH by the N-terminal region encompassing 
residues 3-15 (Gut et al., 2006). The triple helical bundles are structural 
elements that were shown to be involved in recruiting EcGadB to the 
cytosolic side of the inner membrane, in a pH-dependent manner. To date the 
nature of the interaction with the membrane, i.e. protein-protein or protein-
lipid, has not been conclusively established. In EcGadB chloride ions (as well 
as other halides) were shown to act as positive allosteric activators by 
delaying the spectroscopic transition (and the decrease in the activity) to less 
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acidic pH values. In other words chloride ions stabilize the active form, 
absorbing at 420-nm, of EcGadB  (O'Leary & Brummund, 1974, Gut et al., 
2006). Also in BmGadB the pH-dependent spectroscopic transition is 
significantly affected by the addition of 50 mM sodium chloride in the 
buffers used to record the absorption spectra (Fig. 3.6B): the 420-nm species 
persists up to pH 5.2 and the pK of the spectroscopic transition is increased 
by 0.4 pH units (Tab. 3.4). These results are consistent with the conservation 
in the BmGadB sequence of the residues that in EcGadB were shown to be 
involved in halides binding (Fig. 3.3 and (Gut et al., 2006)). However, the 
allosteric effect of chloride ions on BmGadB is apparently unlinked to the 
formation of the triple helical bundles (cfr. 3.1.5). 
 
Table 3.4. Hill parameters from curve fitting of the 420 nm absorbance readings 
as a function of pH 
 n pK 
BmGadB 3,52 ± 0,67 4,97 ± 0,03 
BmGadB + NaCl 7,52 ± 1,58 5,414 ± 0,008 
EcGadB* 12,07 ± 1,82 5,308 ± 0,006 
EcGadB + NaCl* 6,74 ± 0,66 5,690 ± 0,007 
The values reported were calculated using the integrated Hill equation. 
* Data from (Pennacchietti et al., 2009) 
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Figure 3.6. pH-Dependent absorbance changes. (A) Absorption spectra of BmGadB were 
recorded in 50 mM sodium acetate buffer at pH values of 3.5, 4.2, 4.46, 4.6, 5.0, 5.4 and 6.5. 
Spectra were normalized taking into account the full PLP content (11.6 µM). The arrow 
indicates the change in absorbance at 420 nm upon increasing pH. (B) pH-dependent change 
in absorbance at 420 nm in the absence (blue squares) and presence (green squares) of 50 
mM NaCl. The solid lines through the experimental points show the theoretical curves 
obtained using the Hill equation. 
 
To assess whether the pH dependency of the activity of BmGadB follows the 
same trend of the UV-visible spectroscopic changes, Gad activity was 
assayed both in the absence and in the presence of sodium chloride in the pH 
97 
 
range 3.8-6.5. Similarly to the E. coli counterpart (Gut et al., 2006), BmGadB 
displays its maximal activity at low pH, but only up to pH 4.5 (Fig. 3.7). 
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Figure 3.7. Effect of pH on the activity of BmGadB. Glutamate decarboxylase activity (units 
mg) was measured at 37°C in 50 mM sodium acetate (pH 3.8 - 5.8) or phosphate (pH 6.0 - 
6.5) buffer containing 40 µM PLP, 50 mM glutamate and in the absence (blue squares) or 
presence (green squares) of 50 mM NaCl. The protein concentration is 0.5-2 µM. The solid 
lines through the experimental points represent the theoretical curves obtained using Hill 
equation. Hill parameters from curve fitting of the specific activities as a function of pH are 
provided in the inset. 
 
At pH ~ 5 the enzyme exhibits 50% of the specific activity measured in the 
pH range 3.8-4.5 and becomes inactive at pH values higher than 5.6. The data 
of activity versus pH fit well to the Hill equation suggesting that 
cooperativity (n = 3) in the activity occurs. Notably, in the pH range 3.8-5.3 
BmGadB is 1.5-3 times more active when chloride ions are present. Notably, 
the shift of 0.4 pH units observed in the spectroscopic transition (Fig. 3.6B) 
does not lead to a similar shift in the pH range of activity of the enzyme. 
The finding that the enzyme activity is still measurable at pH 5.4, i.e. where 
the 420-nm active form is undetectable, suggests that during the activity 
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assays the presence of glutamate delays the conversion between the active 
and the inactive forms, as proposed for EcGadB (Pennacchietti et al., 2009).  
3.1.4  Fluorescence properties  
Fluorescence analysis provides useful insights into the nature of the 
cofactor species embedded in the active site at different pHs. When BmGadB 
in a buffer at pH 4.0 was excited at 430 nm, the emission spectrum (with a 
maximum at 500 nm) was typical of the ketoenamine, which on the contrary 
is barely detectable when the enzyme is excited at the same wavelength but at 
neutral pH (Fig 3.8A). These data are similar to those reported for E. coli 
GadB (Pennacchietti et al., 2009) and, in combination with the UV-visible 
spectra, confirm that the active form of BmGadB has the internal aldimine 
protonated on the imine nitrogen, a pre-requisite for being catalytically 
competent. 
In order to discriminate on the chemical nature of the 340-nm absorbing 
species (Fig. 3.6A), i.e. substituted aldamine or enolimine, the emission 
spectrum of BmGadB, following excitation at 345 nm, was recorded both at 
acidic and near-to-neutral pH. In EcGadB at pH > 5.5 the residue His465 is 
responsible for the formation of a substituted aldamine (Gut et al., 2006), 
which emits with a maximum at 390 nm when excited at 345 nm, whereas the 
corresponding His465Ala mutant exhibits, in addition to an emission at 390 
nm, a second emission band at 510 nm (Fig. 3.8C). This latter emission 
spectrum is characteristic of the enolimine tautomer of the internal aldimine, 
i.e. with the hydrogen on the phenolic oxygen typical of internal aldimines in 
a less polar environment ((Pennacchietti et al., 2009) and references therein). 
Similar results were obtained with EcGadB by exciting at 295 nm and 
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recording the fluorescence emission spectrum in the range 300-540 nm, 
though in this case the emission maxima were detected at 355 and 520 nm 
(Pennacchietti et al., 2009). 
In the BmGadB sequence His462 and His463 occupy the last but two and 
penultimate position, respectively (Fig. 3.3). Therefore the possibility exists 
that also in BmGadB the 340-nm species, corresponding to the inactive form 
of the enzyme, arises from the formation of a substituted aldamine. Indeed 
fluorescence emission spectra obtained by exciting either at 295 nm (Fig. 
3.8B) or at 345 nm (Fig. 3.8C) provide a strong indication that in BmGadB 
aldamine is formed; in fact only one maximum is detected at 350 nm and 390 
nm, respectively (Fig. 3.8B and C). At present we cannot unequivocally 
assign aldamine formation to any of the two histidine residues, though based 
on the sequence alignment we propose His463 in BmGadB as the most likely 
candidate. 
Overall the UV-visible and fluorescence emission spectra provide a clear 
indication that PLP in the active site of BmGadB at neutral pH is in the form 
of a substituted aldamine, strongly suggesting that the reversible inactivation 
mechanism which was shown to be operative in EcGadB is conserved in 
BmGadB. 
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Figure 3.8. Fluorescence emission spectra at different pHs. BmGadB emission spectra were 
recorded at pH 4.0 (red line) and at pH 6.5 (blue lines) following excitation at 430 nm (A) 
and 295 nm (B). (C) Emission spectra of BmGadB (blue line), EcGadB (black line) and 
EcGadB-H465A (green line) were recorded following excitation at 345 nm at pH 6.5. The 
protein concentration of BmGadB was 13 µM. The protein concentration of wild type 
EcGadB and GadB-H465A mutant was 3 µM. The buffers used were 50 mM sodium acetate 
at pH 4.0 and 50 mM potassium phosphate at pH 6.5. 
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3.1.5  pH-dependent cellular partition 
In E. coli the acid-induced formation of two triple helical bundles, 
provided by the N-terminal regions of each subunit in the GadB hexamer, 
participates in the recruitment of the protein to the inner membrane (cfr. 
1.1.3.2). The relocalization of EcGadB in the cell, i.e. at the cytosolic side of 
the inner membrane, was proposed to be beneficial because this district is that 
mostly affected by incoming protons (Capitani et al., 2003, Pennacchietti et 
al., 2009). 
Secondary structure predictions tools confirm that the N-terminal sequence of 
BmGadB (which includes a Pro residue in the 7
th
 position) does not support 
formation of α-helical bundles, which on the contrary are predicted to be 
formed in the N-terminal region of EcGadB (Fig. 3.9), in agreement with the 
crystal structure. Although BmGadB and EcGadB share 73 % amino acid 
sequence identity, the sequence alignment reveals that the two sequences 
mostly diverge in the N-terminal and C-terminal regions, with the notable 
exceptions of residues Ser14, Phe16, Gly17 and residues Pro459, Phe461, 
His463 and Thr464, the equivalent positions of which were shown to be 
instrumental in EcGadB for chloride binding and active site plugging, 
respectively (Fig. 3.3). The N-terminal triple helical bundles in E. coli 
possess a hydrophobic core formed through one and a half heptad repeats 
(VTDLRSEL) and are polar/charged on the outside. The N-terminal region 
of BmGadB does not possess any of these features and in addition it lacks the 
residues corresponding to Asp2, Asp8 and Asp15 of EcGadB (Fig. 3.9A), the 
protonation of which is a likely requirement in driving triple helices 
formation. 
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E. coli     ------MDKKQVTDLRSELLDSRFGAKSISTIAESKRFPLHEMRDDVAFQIINDELYLDG  54 
B. microti  MKITLEVIMTGSNYPARDLIASVFGTEALQEIAASRGFPEKEMQANAVYQIIHDELFLDG  52 
                  :  .  .    :*: * **::::. ** *: ** :**: :..:***.***:*** 
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Figure 3.9. Secondary structure prediction of BmGadB N-terminal region. (A) Clustal 
Omega (version 1.2.0) alignment of EcGadB and BmGadB (only N-terminal portion is 
shown). In EcGadB: the residues in bold correspond to residues involved in α-helix 
formation; blue shaded residues contribute to the hydrophobic core of the bundle ; yellow 
shaded residues are the charged residues. In BmGadB: the first 8 amino acids (barred) are not 
part of GadB protein, as determined experimentally; the red residue is the proline. Secondary 
structure prediction of EcGadB (B) and BmGadB (C) N-terminal regions, performed with 
PSIPRED. Conf: confidence of prediction. Pred: predicted secondary structure (violet 
cylinders represent α-helices, H, and black lines random coil regions, C). 
 
Despite the apparent inability to form an α-helix in the N-terminal region of 
each subunit of the hexamer, BmGadB might still possess the ability to 
partition between the cytosol and the membrane following a decrease in 
cytoplasmic pH. In order to answer to this issue, cell fractionation of the E. 
coli strain BL21(DE3) overexpressing BmGadB was performed by 
ultracentrifugation. Cytoplasmic and membrane fractions at neutral and 
mildly acidic pH were assayed for enzyme activity (Fig. 3.10A) and analysed 
by SDS-PAGE (Fig. 3.10B). As hypothesized on the basis of the secondary 
structure predictions, the cellular localization of BmGadB is not influenced 
by pH: a significant fraction of the protein (approximately 30%) is already 
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associated to the membrane at neutral pH and its levels do not increase 
further upon decreasing the pH of the cell extract. 
S                 C                    M
pH 7.2 pH 5.1 BmGadB
S           C            M           S           C           M
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B
 
Figure 3.10. Effect of pH on the cellular localization of BmGadB. Cell supernatants (S), 
obtained after cell lysis and centrifugation to remove cell debris; the cytoplasmic (C) and 
membrane (M) fractions were obtained as described in previously (Capitani et al., 2003). A) 
The decarboxylase activity is provided as percentage with respect to the starting activity in S. 
B) The relative abundance of BmGadB in each sample at the specified pH was compared by 
12% SDS-PAGE of 30 µg-samples. For comparison BmGadB (52 kDa, 2 µg) on the right. 
3.1.6  Discussion 
In the present work overexpression, purification, biochemical and 
spectroscopic characterization of recombinant GadB from B. microti 
(BmGadB) is reported. To our knowledge, this is the first report of a Gad 
from an Gram-negative α-Proteobacterium and from the genus Brucella 
which is regarded as highly pathogenic (Franco et al., 2007). The purity of 
BmGadB was over 95%, which allowed to perform a comparative 
characterization with the biochemical and spectroscopic properties of the 
intensively investigated  EcGadB (De Biase & Pennacchietti, 2012).  
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The finding that BmGadB undergoes spectroscopic (UV-visible and 
fluorescence) and activity changes and is affected by chloride ions just like 
EcGadB provides a strong evidence that also in BmGadB occur the 
conformational changes in the C-terminal region that were reported to affect 
the intracellular activity of the E. coli enzyme. 
The role of chloride ions as positive effectors of the enzyme activity in the 
acidic pH range is even more evident in BmGadB than in E. coli GadB. 
However, BmGadB is also peculiar in that it is maximally active up to pH 4.5 
and the allosteric effect of chloride ions is apparently unlinked to the 
formation of triple helical bundles in the N-terminal region, which in E. coli 
GadB were shown to contribute to the cooperativity of the system as well as 
to the recruitment of the enzyme to the cytosolic side of the inner membrane. 
The experiments of cellular partition of BmGadB suggest that the interaction 
of this protein with some components of the inner membrane is not 
significantly affected by acidification of the intracellular compartment. 
However we cannot exclude that in the inner membrane of E. coli some 
components, present in B. microti and responsible for driving BmGadB 
intracellular re-localization in response to acidic stimuli, are actually missing.  
Although the physiological function of BmGadB has been elucidated, i.e. 
it  plays a pivotal role in B. microti extreme acid resistance (Occhialini et al., 
2012), it is possible that protection is also contributed by the protein products 
of other genes besides gadB and gadC, as for E. coli. In this respect it should 
be recalled that in B. microti,  as well as in other Brucella species, the gadBC 
genes is located immediately upstream of the ybaS (BMI_II336) and the hdeA 
(BMI_II337) genes with which they constitute an operon (Occhialini et al., 
2012). The hdeA gene codes for a periplasmic protein that functions at low 
pH and contributes to acid resistance in B. abortus and is regulated by the 
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RNA chaperone and post-transcriptional regulator Hfq (Valderas et al., 
2005). The role of acid-induced periplasmic chaperones has been investigated 
in E. coli  because they are part of the AFI (cfr. 1.1.2. and Fig. 1.3) and 
because of their peculiar mode of action. Periplasmic chaperone HdeA 
contributes to acid resistance in a range of different species, including E. coli, 
S. flexneri and B. abortus (recently reviewed by (Hong et al., 2012)). In all 
these species (which infect with a low ID), loss of one or both of the 
periplasmic chaperons impairs growth at low pH. The molecular details of 
their mode of action are beginning to be elucidated (Tapley et al., 2010, 
Zhang et al., 2011, Foit et al., 2013). Moreover the role of ybaS, coding for a 
glutaminase, in B. microti is likely to be the same as that described recently 
for the E. coli counterpart (cfr. 1.1.1 and Fig. 1.1A). 
 
With the present work we aimed at obtaining detailed information on a 
novel prokaryotic GadB. This work not only contributes to our understanding 
of the GadB-mediated mechanism protecting bacteria from acid stress 
(together with the urease system it is in fact the most potent AR system 
known in neutrophilic bacteria), but also has allowed to discriminate between 
biochemical differences which might reflect not only the differences in the 
physiology and metabolism of the two specific microorganism but also in the 
niches they occupy. 
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3.2 PART II: The Asp86-His465 mutant of Escherichia coli 
glutamate decarboxylase exhibits improved GABA synthesis at 
alkaline pH 
As described in the introduction, E. coli GadB was extensively 
characterized at the biochemical and structural level (Capitani et al., 2003, 
Gut et al., 2006). Its pH-dependent activation relies on important local 
structural reorganizations (Capitani et al., 2003, Gut et al., 2006) and can be 
easily monitored by the change in the absorption spectrum of PLP, which 
probes it. At  neutral pH, the C-tail (the last 15 residues) was found to plug 
the active site and reversibly inactivate the enzyme via formation of the 
substituted aldamine. 
Spectroscopic analyses of His465 mutants demonstrated that this residue 
is indispensable for the reversible inactivation of the enzyme at neutral pH, 
but does not contribute to the cooperative change of GadB activity 
(Pennacchietti et al., 2009). Even though the GadB-His465 mutant enzymes 
display a pH-range of activity broader than that of the wild type enzyme, 
their catalytic activity falls at pH 6.0, i.e. much before the spectroscopic 
transition midpoint (pH ≈ 7.5) occurs. The decrease of the catalytic activity 
as a function of increasing pH was thus attributed to the deprotonation of 
substrate-binding or catalytic residues, with an expected pK of 6.0 
(Pennacchietti et al., 2009). One such candidate could be Asp86, which is 
involved in the binding of the distal γ-carboxylate of glutamate and of which 
the ionizable side chain takes up different conformations at neutral and acidic 
pH (Capitani et al., 2003, Pennacchietti et al., 2009) (Fig. 3.11). Notably the 
role of Asp86, strictly conserved in the pH-dependent prokaryotic and plant 
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GADs, is replaced by a non-ionizable glutamine residue and a positively 
charged arginine residue in both human GADs, which indeed display 
maximal activity at neutral pH (Fenalti et al., 2007). 
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Figure 3.11. Active site of wild-type EcGadB at neutral and acidic pH. (A) At neutral pH, 
the C-tail is directed into the active site precluding the access of the substrate. Residue 
His465 is involved in the formation of the substituted aldamine with PLP-Lys276 Schiff base 
Asp 86* side chain points away from the active site. (B) At acidic pH the C-tail no longer 
blocks the active site and the residue Asp86* changes orientation, moving in the direction of 
the acetate molecule (present in the crystallization buffer), which mimics the γ-carboxyl 
group of the substrate glutamate. 
 
In order to elucidate the role of Asp86, a biochemical and structural 
characterization of the GadB_Asp86Asn-His465Ala mutant (hereafter named 
GadB-D86NH465A), which incorporates the mutation Asp86Asn in the 
already characterized GadB-His465Ala mutant (Pennacchietti et al., 2009), 
was performed.  
The production of GadB-D86NH465A mutant, its purification and 
spectroscopic analysis was the subject of my MSc thesis. During my Ph.D. I 
continued to work with this mutant with the aim to improve the purification 
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protocol, perform a more detailed analysis of the catalytic properties and 
interpret the structural data obtained in the meanwhile on crystals of highly 
pure protein which was provided to Dr. Guido Capitani (Paul Scherrer 
Institute, PSI Villigen, Switzerland). 
3.2.1 Preliminary data: purification and spectroscopic properties 
of GadB-D86NH465A 
The double mutant, GadB-D86NH465A, was generated by incorporating 
the Asp86Asn mutation into the single mutant protein GadB-His465Ala 
already available in our laboratory (Pennacchietti et al., 2009). GadB-
D86NH465A was overexpressed in E. coli and purified as previously 
described (De Biase et al., 1996) except that the DEAE-Sepharose 
chromatography was carried out at pH 6.0 instead than at pH 6.5, because at 
the latter pH GadB-D86NH465A did not bind the resin. The initial 
purification protocol has been further improved by a second DEAE 
chromatography step, where the collected fractions obtained from the first 
run at pH 6.0 were reconstituted with PLP (5-fold of the protein 
concentration) for 1h at room temperature to increase the holo/apo form ratio. 
In fact, in the absence of added PLP during purification, the holoenzyme 
content is approx. 70 %. The reconstituted enzyme was re-loaded on DEAE 
column at pH 6.5. Under these conditions the protein does not bind the 
column resin and is recovered in the flow-through during the washing step, 
while other protein contaminants remain bound to the resin (Fig. 3.12). 
Following the optimized purification GadB-D86NH465A is ≥ 95 % pure (as 
judged by SDS-PAGE) and is stable for several months at 4°C (Fig. 3.12). 
The PLP content is 90-95%. The yield of the purified enzyme from a 
109 
 
standard purification (2 L bacterial culture) is 30 mg. The specific activity 
towards L-glutamate (assayed at 37°C in 0.2 M pyridine/HCl buffer, pH 4.6, 
containing 0.1 mM PLP) is 140 U/mg, corresponding to 64 % and 80 % of 
the specific activity of wild type GadB and GadB-H465A, respectively 
(Pennacchietti et al., 2009). When assayed in the presence of aspartate and 
glutamine, GadB-D86NH465A does not show any detectable activity, thus 
confirming that Asp86Asn mutation in the active site does not affect substrate 
specificity. 
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Figure 3.12. Purification of GadB-D86NH465A. 12% SDS-PAGE, stained with Coomassie 
Blue. Lane 1, GadB-D86NH465A, after a standard purification (7 μg). Lane 2, GadB-
D86NH465A, after the optimized purification (6.5 μg). Molecular mass of protein standards 
are indicated on the left. 
 
As shown in Figure 3.13, the pH-dependent UV-visible spectroscopic 
changes of GadB-D86NH465A differ significantly from those reported for 
wild type GadB (Shukuya & Schwert, 1960, Tramonti et al., 2002), while 
resembling those of GadB-H465A (Pennacchietti et al., 2009). In fact the 
absorption spectra, recorded in the pH range 4.5 - 9.1, show that the 420 nm 
→ 332 nm spectroscopic transition does not undergo completion, and in fact 
42 % of the ketoenamine is still detectable at pH ≥ 9 (Fig. 3.13A). 
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The incomplete spectroscopic transition has a midpoint at pH 7.23, two units 
higher than that of wild type GadB, and cooperativity is abolished (Fig. 
3.13B, Table 3.5.). An isosbestic point is present at 360 nm as in wild type 
GadB, whereas in GadB-H465A it is blue-shifted (348 nm) (Pennacchietti et 
al., 2009). 
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Figure 3.13. pH-Dependent absorbance changes. (A) Spectra of GadB-D86NH465A are 
recorded in 50 mM sodium acetate buffer at pH values of 4.6, 5.27, 5.48 and in 50 mM 
potassium phosphate buffer at pH 6.58, 7.5, 8.26, 8.81, 9.1. The protein concentration is 15.4 
μM and the arrows indicate the change in absorbance at 420 nm and at 332 nm upon 
increasing pH. (B) The pH-dependent readings at 420 nm are reported for GadB-
D86NH465A (green), for GadBH465A (magenta) and wild type GadB (blue). The solid lines 
through the experimental points represent the theoretical curves obtained using Hill equation. 
 
Table 3.5. Midpoint (pK) and Hill coefficient (n) of spectroscopic 
transition in wild type and mutants forms of GadB 
GadB pK n 
wild type 5,31 ± 0,001 10,52 ± 1,48 
H465A 7,11 ± 0,06 0,86 ± 0,08 
D86N-H465A 7,23 ± 0,09 0,86 ± 0,17 
 
Chloride ions, which are known to act as positive allosteric activators of 
GadB (Gut et al., 2006), do not affect further the spectroscopic transition 
(data not shown). 
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3.2.2 Catalytic Properties 
3.2.2.1  Effect of pH on specific activity 
All the above findings suggest that Asp86 does not contribute to the pH-
dependent spectroscopic properties of E. coli GadB and that these properties 
in GadB-D86NH465A can be ascribed to the H465A mutation, which is 
shared by GadB-H465A and GadB-D86NH465A. 
To further investigate on the role of Asp86 in E. coli GadB, 
decarboxylation of L-Glu was assayed both at different pH values and at time 
intervals at a specific pH. As shown in Figure 3.13, spectroscopic data 
indicate that in GadB-D86NH465A at neutral pH still a significant fraction 
the coenzyme is present in the 420 nm-absorbing form (ketoenamine), typical 
of a hydrated active site. Assuming that the active site is still accessible to the 
substrate, the possibility exists that the introduction of D86N mutation might 
allow GadB-D86NH465A to bind L-Glu and catalyse its decarboxylation at 
higher pH values than both wild type enzyme and GadB-H465A. In fact, as 
previously mentioned, the midpoint of the partial spectroscopic transition in 
GadB-H465A occurs at pH 7.1 (Table 3.5), which is one pH unit above the 
pH at which 50% of the change in the catalytic activity is detected 
(Pennacchietti et al., 2009). This observation suggested that the catalytic 
activity of GadB, is influenced by an ionisable group with pK 6.0 besides 
being heavily influenced by His465 which is primarily responsible to control 
the access to active site (Pennacchietti et al., 2009). 
The activity profile of GadB-D86NH465A in the pH range 4.6-8.3 was 
compared with that of wild-type GadB and GadB-H465A (Fig. 3.14A). 
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Figure 3.14. Effect of pH on the specific activity and time course of GABA production. Red 
squares, wt GadB; blue triangles, GadB-H465A; green circles, GadB-D86NH465A. (A) 
Activity assays were carried out at 37°C in 50 mM acetate (pH 4.5 - 5.8) or phosphate (pH 
5.9 – 8.3) buffer in presence of 40 µM PLP, 50 mM NaCl and 50 mM L-Glu. Protein 
concentration was 0.9-2 μM. The solid lines through the experimental points represent the 
theoretical curves obtained using the Hill equation. The reported data are the means of three 
independent experiments, with a standard deviation <10 % of the given value. The n and 
Activity Midpoint values retrieved from curve fitting are given in the inset Table. (B) GABA 
production was analysed over a period of 3 hours. The reaction was carried out at 30°C in 4 
ml of 50 mM potassium phosphate buffer, pH 7.0, containing 40 µM PLP and 50 mM L-Glu. 
The protein concentration was 2 μM. At each time point aliquots (100 μl) were withdrawn 
and analyzed for GABA content with the Gabase assay. The pH changes during the reaction 
were also recorded (inset). 
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The data in the above Figure show that GadB-D86NH465A displays an 
enhanced activity in a broader pH range. In particular 6 % of the starting 
activity is still present at pH 8.0. This is noteworthy if one considers that in 
the spectroscopically similar GadB-H465A mutant catalytic activity is 
undetectable above pH 7.2 (Fig. 3.14 and (Pennacchietti et al., 2009)) and 
that in wild type GadB the activity drastically falls at pH > 5.3, 
corresponding to the pK of the spectroscopic transition which leads to 
aldamine formation and therefore autoinactivation. 
Differently from previous work, in which the reactions were carried out in 
phosphate buffer (Pennacchietti et al., 2009) or in water (Lammens et al., 
2009), in the present work the  assays were performed using two different 
buffer to cover such a wide pH range: acetate buffer (4.5 - 5.8) and phosphate 
buffer (pH 5.9-8.3). Under these experimental conditions, in GadB-H465A 
mutant the pH-triggered transition from the active to the inactive form of the 
enzyme is not a cooperative process (n ≈ 1) (Fig. 3.14). The double mutant 
GadB-D86NH465A exhibits a similar behavior. The pH-dependent activity 
profile of wild type enzyme confirms that the transition is still cooperative (n 
≈ 2), as reported in previous works. 
Given that GadB-D86NH465A is still active at pH close to 8.0, it was 
decided to assay GABA production in potassium phosphate buffer at pH 7.0 
over a period of 3 hours (Fig. 3.14B). For comparative purposes the time 
course of GABA production was analysed in the presence of 50 mM L-Glu 
for the three enzymes, GadB-D86NH465A, GadB-H465A and wild type 
GadB. As shown in Figure 3.14B, GadB-D86NH465A converts approx. 86 % 
and 96 % of L-Glu into GABA after 2 and 3 hours of reaction, respectively. 
Following the first hour of reaction, the rate at which it occurs gradually 
decreases due to L-Glu consumption which after 3 hours is only 2 mM. These 
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results are remarkable when compared with those obtained with GadB-
H465A, which converts only 35 % of L-Glu into GABA after 3 hours. As 
expected, wild-type GadB decarboxylates only 0.2 % of glutamate after 3 
hours. During reaction, the pH of the solutions was monitored: after 3 h the 
pH was increased by 0.2 and 0.4 pH units in GadB-H465A and GadB-
D86NH465A reaction mixtures respectively, coherently with H
+
 
consumption due to the decarboxylation reaction. In the GadB wild type 
sample no pH changes was recorded.  
3.2.2.2 Kinetic constants and solvent isotopic effect 
The kinetic constants of the reaction catalyzed by GadB-D86NH465A 
were obtained at 25°C in 50 mM acetic acid/sodium acetate buffer at pH 4.6, 
varying the substrate concentration from 0.3 to 80 mM. Since it was not 
possible to follow the reaction spectrophotometrically (De Biase et al., 1996), 
the reaction rate was determined by measuring the accumulation of GABA at 
1 min time intervals by Gabase assay (cfr 2.6.3). This was possible since the 
decarboxylation reaction is irreversible.  
The kcat and Km values calculated for GadB-D86NH465A are provided in 
Table 3.6 and compared with those of GadB wild type and H465A mutant. 
Km of GadB-D86NH465A is significantly higher than that calculated or the 
other two enzymes, while kcat is only slightly increased. This results in an 
overall reduction of the specificity constant (kcat/Km). 
The decarboxylation reaction was also conducted both in water and in 
deuterium oxide under saturating conditions, and by keeping the pH (or pD) 
of the reaction constant at 4.6 (cfr 2.6.4). 
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Table 3.6. Kinetic parameters of GadB-D86NH465A compared to GadB wild type 
and GadB-H465A. 
GadB kcat s
-1
  Km (mM) kcat/Km (s
-1
 mM
-1
) 
wild type 18,1 ± 1,2 0,68 ± 0,09 26,4 ± 5,3 
H465A 16,1 ± 0,4 0,82 ± 0,05 19,6 ± 1,7 
D86N-H465A 27,1 ± 2,1 2,60 ± 0,32 10,45 ± 2,1 
The values reported were calculated from the experimental data using the Lineweaver-Burk 
equation.  
 
The kcat of the reactions carried out by GadB-D86NH465A, GadB-H465A 
and wild type enzyme, were determined in both conditions and compared, to 
determine the solvent isotope effect (Table 3.7). In fact, it is known that E. 
coli glutamate decarboxylase undergoes a marked solvent isotope effect on 
kcat (O'Leary et al., 1981, Tramonti et al., 1998).While H465A mutant 
displayed an isotope effect similar to that of wild type enzyme, in GadB-
D86NH465A the isotope effect is still present but reduced more than 5 fold 
respect to  wild type GadB (Table 3.7). Given that the decrease in isotope 
effect is observed only in the double mutant and not in the single H465A 
mutant, and that the residue Asp68 binds the distal carboxylate of L-Glu (i.e. 
stabilizing the interaction with the substrate, which must be properly oriented 
in the active site in order to be decarboxylated at C-α), the present finding 
suggests that the D86N mutation probably affects a stage that involves proton 
transfer before the formation of the substrate-enzyme complex. 
 
Table 3.7. Isotope effect on GadB-D86NH465A kcat compared to GadB wild type and 
GadB-H465A 
GadB kcat s
-1
 in H2O kcat s
-1
 in D2O Isotope effect 
wild type 21,3 ± 0,27 1,48 ± 0,06 14,4 
H465A 32,70 ± 0,87 2,58 ± 0,16 12,7 
D86N-H465A 56,8 ± 0,89 20,7 ± 0,16 2,7 
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3.2.3  Structural analysis 
Highly purified GadB-D86NH465A was provided to the collaborating 
laboratory of  Dr. Guido Capitani (PSI, Villigen, Switzerland) which solved, 
from a pseudomerohedrally twinned monoclinic crystal form, the structure of 
GadB-D86NH465A at pH close to neutrality and at 3.1 Å resolution. The 
crystals possessed two GadB-D86NH465A molecules per asymmetric unit 
mimicking an orthorhombic space group. In spite of the twinning, the 
structure could be refined by taking the twin law into account (G. Capitani 
personal communication). 
The two GadB-D86NH465A molecules in the asymmetric unit display a 
hybrid conformation with the N-terminal regions of each chain being 
disordered, typical of the neutral-pH inactive form of GadB (1PMO), and no 
visible C-tail in the active site, typical of the low-pH active form (1PMM) 
(Capitani et al., 2003, Gut et al., 2006). Also, the β-hairpin formed by 
residues 300-313 is partly disordered, with variations from subunit to subunit. 
Taking one subunit as reference, the conformation resembles more that of the 
low pH form of GadB (1PMM) than that of the neutral pH forms. This latter 
finding suggests that at alkaline pH His465 is instrumental to stabilize the C-
tail in its position and that when this residue is missing not only the C-tail has 
more freedom, but also the 300-313 -hairpin cannot adopt the same 
conformation as in the inactive wild-type GadB, in which it contacts residues 
461-463 in the C-tail (in 1PMO). 
The active site of GadB-D86NH465A (Fig. 3.15) exhibits a conformation 
very similar to that of the wild type enzyme at both low-pH (1PMM) and 
neutral-pH (2DGK, 1PMO), with the following distinctive points: the side 
chain of Asn86 is free from ligands in 10 subunits out of 12, while in the 
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remaining two it is close to additional density corresponding to a ligand in 
the active site (interpreted as acetate, which was present at 150 mM in the 
crystallization solution).  In 3 GadB-D86NH465A subunits out of 12 the 
conformation of Asn86 is similar to that observed for Asp86 in the low pH 
form of GadB (1PMM) and points towards the acetate binding site, while in 
the other 9 it is very similar to that of Asp86 in the neutral-pH forms (1PMO 
and 2DGK). These observations suggest that GadB-D86NH465A has a low 
affinity for acetate and are in accord with the finding that GadB-D86NH465A 
is probably affected by acetate ions to a lesser extent respect to the wild type 
enzyme (Fig. 3.14). 
 
Figure 3.15. Conformation and environment of Asn86 of GadB-D86NH465A and Asp86 of 
GadB at low and neutral pH. Stereo ball-and-stick depiction of the active site of GadB-
D86NH465A (yellow and atom colors) with the active sites of 1PMM (GadB at low pH, 
salmon) and 2DGK (GadB -1-14 at neutral pH, green) superimposed. The aldamine-bound 
C-terminal tail of 2DGK, green, is not seen in the active site of GadB-D86NH465A. An 
acetate ion is present is the depicted active site (chain A) but it absent in the majority of the 
12 active sites in the asymmetric unit. 
3.2.4 Discussion 
In this chapter the analysis of the contribution of Asp86, the residue 
involved in the binding of the γ-carboxyl group of L-Glu , to the catalytic 
properties of E. coli GadB is presented. The GadB-D86NH465A mutant was 
also characterized at the structural level by collaborators, to provide a more 
118 
 
complete picture of the structural/functional consequences of the double 
mutation Asp86Asn-His465Ala in E. coli GadB. 
Based on the analysis of His465 mutants it was proposed that in the absence 
of His465 GadB remains in the open conformation at pH values well above 
pH 6.0, even though the activity significantly decreases at this pH 
(Pennacchietti et al., 2009). This latter finding was attributed to the effect of 
one or more residue(s) directly involved in substrate binding or catalysis. 
Asp86, a residue provided by the neighbouring subunit of the functional 
dimer, is a likely candidate because it undergoes a significant side chain 
reorientation during the pH-dependent conformational changes (Capitani et 
al., 2003) and the pK of the its
 β-carboxylate might directly correlate with the 
pH-dependency in the enzyme activity. At acidic pH the side-chain of Asp86 
is tilted towards the active site and its β-carboxylate interacts with an acetate 
ion, mimicking the γ-carboxylate of the substrate glutamate (Fig. 3.11). For 
this interaction to occur clearly at least one (if not both) of the two 
carboxylate groups must be protonated (Capitani et al., 2003).  
To assess the role of Asp86 in E. coli GadB, GadB-D86NH465A double 
mutant was produced. This was necessary to appreciate the contribution of 
Asp86 in substrate binding, an interaction otherwise undetectable because of 
the presence of His465 in the active site at pH > 5.5. Asp86 was replaced 
with a similarly sized, but neutral Asn residue. This mutation was expected 
not to affect polarity in the GadB active site. The intention was to abolish the 
charge repulsion with the γ-carboxylate of glutamate at non permissive pH (> 
5.5) thus allowing substrate binding at pH values well above 6.  
Preliminary data confirmed that Asp86Asn mutation in the double mutant 
GadB-D86NH465A does not affect the spectroscopic properties (cfr. 3.2.1) 
with respect to the single mutant GadB-H465A, i.e. mutating His465 is
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sufficient to unlock the active site. However the data obtained in this thesis 
show that GadB-D86NH465A has an expanded pH-range of activity, i.e.  
GadB-D86NH465A is able to catalyze the decarboxylation reaction at a 
significant rate at pH 7.0, where the activity of both GadB-H465A and wild 
type GadB is greatly reduced or practically nil.  
The Asp→Asn substitution might have altered the non-covalent 
interactions system (e.g. hydrogen bond) involved in substrate anchoring. A 
non-optimal initial interaction with glutamate might explain the worsened 
substrate affinity (higher Km) at acidic pH. However, following substrate 
binding, L-Glu might be in a more favourable location for the subsequent 
reaction steps (higher kcat). The kinetic constants and isotope effect 
discrepancies between GadB-D86NH465A and both GadB wild type or  
H465A mutant suggest that the above are likely possibilities.  
Structurally, GadB-D86NH465A, present in two copies in the asymmetric 
unit, exhibits features of both the low-pH (1PMM) and the neutral-pH 
(2DGK, 1PMO) forms of the enzyme: its C-terminal tail is disordered and the 
active site is accessible to bulk solvent, like in 1PMM, while the N-terminal 
helical bundle is absent like in 1PMO. Even though, the lattice of the GadB-
D86NH465A crystals does not provide enough space to accommodate all N-
terminal bundles, if they formed, it is reasonable to assume that at pH ~7.0 
(the pH of the crystallization drop) the N-terminal bundles are not present, as 
suggested by previous experiments (Pennacchietti et al., 2009). In the active 
site, Asn86 is found in a conformationally mixed situation with respect to the 
two canonical wild-type structures (i.e. low pH and neutral pH) and no 
ligands are found only in a fraction of the active sites. The full accessibility 
of the active site at a pH around 7 is in accord with the biochemical data. In 
spite of the presence of 0.3 M sodium acetate in the reservoir solution of the 
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crystallization setup, an acetate ion is found only in two active sites out of 12 
at the site observed in 1PMM, where Asp86 is involved in the binding. 
 
The availability of a GadB-D86NH465A mutant, which is active in a 
broad pH range, could have important implications in the biotechnological 
field, where wild type GadB has already been proposed to be used. In fact, 
GadB may be immobilized in bioreactors for industrial production of GABA, 
to be used as an intermediate for the synthesis of precursors of biopolymers 
(Introduction 1.3.2). The enzymatic conversion of L-Glu to GABA via E. coli 
GadB, carried out in bioreactors at the industrial level, was proposed as a 
strategy to decrease the dependence on fossil fuels, allowing the production 
of chemicals from renewable resources, such as biomass (Lammens et al., 
2009). However, during L-Glu decarboxylation GadB activity is slowed 
down by the pH rise caused by the consumption of protons (Lammens et al., 
2009, Pennacchietti et al., 2009). To circumvent this problem, Lammens et 
al. showed that the optimal pH for the decarboxylation reaction could be kept 
constant by the addition of L-Glu (acid) in an unbuffered fed-batch reaction 
which uses immobilized E. coli GadB (Lammens et al., 2009). Working in a 
buffer-free system had also the advantage of making the downstream 
separation steps easier. However, at acidic pH glutamic acid displays a very 
low solubility (Amend & Helgeson, 1997), a limiting factor for GABA 
production in a batch mode.  
The GadB-D86NH465A mutant characterized in this thesis is expected to be 
useful because, unlike wild-type GadB, it is able to catalyze the 
decarboxylation reaction across a wider pH range that extends toward pH > 
8.0, thereby rendering the pH of the reaction not a limiting parameter. 
Beyond the results presented in this thesis, many other studies in recent years 
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have focused on enhancing GABA production and improving the catalytic 
properties of bacterial GAD. Thus engineered E. coli GadB, such as a C-
terminal truncated mutant (Yu et al., 2012), His465 mutants (Pennacchietti et 
al., 2009) Glu89/His465 mutants (Ho et al., 2013) and GadB mutants 
extended or reduced in length by just one residue at the C-terminus (Kang et 
al., 2013) were designed with the aim of improving and enhancing the 
enzymatic properties of GAD and the reaction conditions for potential 
industrial applications. 
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3.3 PART III: Preliminary structural analysis of Escherichia coli 
glutamate decarboxylase apo form 
Although the biochemical properties of E. coli glutamate decarboxylase 
have been extensively investigated (cfr. 1.1.3.2 and 1.2.2), the structural role 
of PLP in protein folding, oligomeric assembly and stability, has not been 
completely elucidated and represents an interesting topical of research. 
Recently, the structure of the apo form of another member of group II 
decarboxylase family, i.e. the human L-DOPA decarboxylase (DDC), was 
solved (Giardina et al., 2011). As other mammalian decarboxylases, DDC is 
a homodimer. Comparing available structure of the homolog pig kidney 
enzyme in the holo form with that of the human apoenzyme, it was clear that 
PLP binding triggers a dramatic conformational rearrangement consisting of 
a rigid body displacement of the dimer subunit large domains, that move by 
20 Å assuming a totally open conformation (Giardina et al., 2011). In the apo 
form the dimer interface is reduced and active sites are completely exposed to 
solvent. In this condition, the global enzyme shape changes, key structural 
elements are mobile or unfolded, and regions that were buried inside the 
closed holo-structure become solvent exposed, giving a reasonable 
explanation for the instability and preferential degradation of the apo form in 
vivo (Matsuda et al., 2004). Furthermore, a combination of structural and 
kinetic analysis allowed to unveil the mechanism of cofactor binding to the 
open structure (that exist as a dynamic system of alternative conformations). 
The entry of PLP into the active site activates an initial conformational 
change, where the rearrangement of loop1 is likely transmitted from the 
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active site region to other structural elements leading to the transition into the 
closed-state (Giardina et al., 2011). 
The unexpected structural reorganization observed in human apoDDC 
may also occur in other members of group II decarboxylases, such as GadB. 
The active form of the bacterial E. coli GadB consists in a homoexamer of 
320 kDa (53 kDa per subunit), composed of three functional dimers (Capitani 
et al., 2003). Dissociation of PLP in certain conditions, i.e. cooling of the 
purified enzyme in diluted solution, was hypothesized to be related to 
structural rearrangements (Shukuya & Schwert, 1960). As described in the 
introduction (1.2.2), electron microscopy investigations of E. coli glutamate 
decarboxylase indicated that the oligomeric state of the enzyme depends on 
several factors, including temperature, protein concentration, PLP and pH. 
The hexameric apoenzyme dissociate into the dimers upon increasing of pH 
above 6, and the dissociation is totally reversible through the addition of the 
cofactor to the solution (Tikhonenko et al., 1968). The structural features of 
the apodimers however have not been further investigated. 
The goal of this preliminary study was to separate the different oligomeric 
species. This consisted in isolating dimeric apoGadB by gel filtration 
chromatography at a sufficient level of purity, i.e. no contamination from 
hexamer or other intermediate oligomers, and to use the apodimers for 
crystallization experiments and structural-functional analysis. 
3.3.1 Gel filtration chromatography 
Recombinant E. coli GadB was purified in the holo form, as described by 
(De Biase et al., 1996) (cfr. 2.5). The apo form was prepared from holoGadB 
performing the abortive decarboxylation-transamination (cfr. 1.2.1) of the 
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substrate analogue α-methyl-glutamate (more prone to the side reaction 
compared to L-Glu), that leads to the formation of 4-oxo-valerate and 
pyridoxamine 5'-phosphate (PMP), with consequent inactivation of the 
enzyme. The reaction was followed spectrophotometrically (De Biase et al., 
1991) and PMP was removed by a gel filtration step, in which the protein 
was eluted in a buffer with an alkaline pH (50 mM HEPPS / 150 mM NaCl 
pH 8, containing 0.1 mM DTT) (Fig. 3.16). In these conditions (pH > 6) 
apoGadB is expected to dissociate into dimers (cfr. 1.2.2; (Tikhonenko et al., 
1968)). In order to separate the dimer from the other oligomeric forms,  likely 
to be present in solution in equilibrium with the dimer, the protein was loaded 
onto a gel filtration Superdex G200 column and eluted in the same HEPPS 
buffer at pH 8 (cfr. 2.6.7). 
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Figure 3.16. apoGadB preparation. Absorption spectra of EcGadB (3.6 mg/ml) in 0.2M 
pyridine/HCl buffer pH 4.6 containing 0.1 mM DTT: before (red, holoGadB) and after (blue) 
incubation with α-methyl-Glu. The 420 nm-absorbing species (ketoenamine) is replaced by 
the 325 nm-absorbing species, which corresponds to PMP. In the inset, the spectrum of 
apoGadB (10 µM) after gel filtration (PD10) in 50 mM HEPPS buffer / 150 mM NaCl buffer 
pH 8, containing 0.1 mM DTT. 
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The chromatogram showed two sharp peaks at 12,9 ml and 14,6 ml (Fig. 
3.17): the fastest eluting corresponding to a putative tetramer (229 kDa) and 
the slowest consistent with a dimer (108 kDa). The dimeric form is prevailing 
over the putative tetramer (the peak is 1.75 times higher). The minor peak at 
9,4 ml is likely the product of protein aggregates. The fractions were 
analysed spectrophotometrically (no absorbance was recorded in the 300-500 
nm region) and those corresponding to the dimer were collected with the aim 
of analysing this species by crystallography.  
To confirm that in these conditions the equilibrium between the dimer and 
the hexamer depends on PLP-binding, apoGadB was reconstituted with an 
excess of PLP (five times the enzyme concentration) and loaded onto the gel 
filtration column. The chromatogram was composed of four peaks (Fig. 
3.17): the first (Ve = 8.6 ml) can be attributed to protein aggregates, the 
second corresponds to the hexamer or a combination of hexameric and 
tetrameric forms (275 kDa), the third corresponds to the dimer (110 kDa), 
while the last peak corresponds to PLP (that was present in excess in the 
sample solution). Preliminary data confirmed that at pH > 6 the holoGadB 
eluted as a single peak corresponding to the hexamer (312 kDa, data not 
shown). The absorption spectra of the fractions showed that PLP was indeed 
bound to the protein (data not shown). The addition of PLP shifted the 
equilibrium toward the hexamer formation and the relative ratio between the 
two peaks was inverted, with the peak corresponding to the 275 kDa species 
1.74 times higher than that of the 110 kDa species. The overall result is a 
relative decrease of the dimeric form of 3 times. 
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Figure 3.17. Gel filtration cromatography of apoGadB at pH 8.0. Gel filtration analysis was 
performed in 50 mM HEPPS/ 150 mM NaCl buffer containing 0.1 mM DTT, at a flow rate 
of 0.5 ml/min, at 4°C. In blue, apoGadB (approx. 7 mg). In red apoGadB (approx. 7.8 mg) 
reconstituted 1h 4°C with an excess of PLP. Peaks with Ve = 8-10 ml can be attributed to 
protein aggregates, while the last peak (Ve = 22.1 ml) corresponds to PLP. Inset: calibration 
curve. HMW Calibration Kit (GE Healthcare) included ferritin (440 kDa; a), aldolase (158 
kDa; b), conalbumin (75 kDa; c), ovalbumin (44 kDa; d). 
3.3.2 Crystallization and structural analysis 
With the aim of analysing the dimeric apoGadB by X-ray crystallography, 
I visited Dr. Guido Capitani’s team for two months at the Biomolecular 
Research Laboratory (BMR) at Paul Scherrer Institut (PSI, Villigen, 
Switzerland). 
Dimeric apoGadB isolated by gel filtration chromatography was crystallized 
using the vapour diffusion sitting drop method (cfr. 2.7.1) at 20°C. Several 
crystallization trials were set up in order to find the best conditions for 
crystallization. In parallel, a microseeding experiment was also performed 
with the purpose of obtaining larger single crystals (cfr. 2.7.1). 
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Single crystals grew in several conditions within weeks and some of them 
achieved a sufficient size (25-30 µm; Fig. 3.18) to be tested with X-rays, 
using the Swiss Light Source at PSI (cfr. 2.7.2). Diffraction data were 
collected to 3 Å resolution from a crystal obtained in 0.1 M Tris pH 8.5 
buffer / 0.3 M sodium acetate, containing 25% w/v PEG 2K MME. 
 
 
Figure 3.18. Crystal of dimeric apoGad. 
 
Since several crystallographic structures of E. coli GadB are available 
(Capitani et al., 2003, Gut et al., 2006) we tried to solve the structure 
employing the molecular replacement method. The neutral-pH form of GadB 
(1PMO) with the first 56 residues removed (start at Arg57) was used as a 
model. Although the large domain of apoGadB was superimposable with our 
model, it was not possible to derive an electron density map of the protein. 
Most likely we have incurred in a difficult case of twinning, a condition that 
occurs when the crystal is composed of distinct domains whose orientations 
differ but are related in a particular, precise way (twin law). 
3.3.3  Discussion 
The preliminary study described in this chapter lays the foundation for an 
in-depth study on the quaternary structure rearrangement and conformational 
changes within the subunits induced by cofactor dissociation in E. coli GadB 
and more in general on the structural role of PLP in protein folding. 
Interestingly, the apoenzymatic forms of several decarboxylases (and other 
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PLP enzymes) are associated with a lower stability (Chen et al., 1998) and 
preferential degradation of the protein in vivo (Matsuda et al., 2004), and 
might be involved in autoimmunity in humans. 
The experimental hypothesis of this work consisted in the assumption that 
the structure of E. coli GadB apodimer may experience a wide 
conformational rearrangement, similar to that observed in human apoDDC 
(Giardina et al., 2011), leading to a different positioning of entire domains 
and a global change of the entire protein structure with respect to the simple 
structure of dimers composing the hexameric holoenzyme. 
Gel filtration chromatography turned out to be a suitable method to both 
discriminate between the multiple oligomeric states of GadB (i.e. hexamer, 
tetramer and dimer) and to isolate for preparative purpose the dimeric 
apoenzyme (by performing the separation of the apoform at alkaline pH). The 
optimization of this part of the work constitutes a prerequisite to perform 
structural studies on an extra pure sample. 
Initial crystallization trials have defined the conditions for a successful 
protein crystallization. In fact, several diffracting crystals were obtained and 
diffraction data were collected at a reasonable resolution for detecting large 
conformational changes. Unfortunately, it was not possible to solve the 
structure by the molecular replacement method.  
The structural analysis of dimeric apoGadB will be tackled also using other 
analytical techniques such as analytical ultracentrifugation, SAXS and 
multiangled light scattering, which might help if X-ray crystallography will 
not be successful or to implement the structural information from X-ray 
analysis. 
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3.4 Conclusions and perspectives 
In the present thesis, I performed a detailed biochemical and spectroscopic 
characterization of a new bacterial Gad (GadB from B. microti, namely 
BmGadB), the first from the genus Brucella, and I gave a contribution to the 
understanding of catalytic and structural aspects of the most investigated E. 
coli GadB. 
The first part of this thesis focused on the expression, purification and 
biochemical characterization of BmGadB, which  turned out to share with the 
E. coli homolog the autoinhibition mechanism that involves the formation of 
a substituted aldamine and the allosteric activation triggered by chloride ions 
(Gut et al., 2006, Pennacchietti et al., 2009). On the other hand, BmGadB 
exhibits peculiar features concerning the pH range of activity (more acidic) 
and the cellular localization (not influenced by pH), that in E. coli involves 
pH-dependent conformational changes of the N-terminal regions (Capitani et 
al., 2003). 
Besides representing the first detailed biochemical study on a bacterial Gad, 
other than E. coli GadB, this work is part of a wider project in collaboration 
with A. Occhialini (CPBS, CNRS, Montpellier, France) which includes the 
characterization of the gadBC operon in B. microti (Occhialini et al., 2012) 
and in other new Brucella species possessing potentially functional GDAR 
system (i.e. B. inopinata BO1, B. inopinata-like BO2 and Brucella sp. strains 
isolated from Australian rodents), to determine its relevance in the 
pathogenesis. 
One of the aims of this thesis consisted in the completion of the 
characterization of a site-directed EcGadB mutant regarding residues His465, 
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responsible for the reversible inactivation of the enzyme, and Asp86, required 
for substrate binding. In addition to gain more insight on the role of specific 
residues in catalysis, this study revealed that GadB-D86NH465A mutant is 
active in a wider range of pH (up to pH 8), a feature that makes it a good 
candidate for biotechnological applications. In fact, the Gad enzyme has been 
proposed to be applicable in industrial production of GABA, an intermediate 
in the synthesis of various bulk chemicals, by immobilizing E. coli GadB in 
bioreactors (Lammens et al., 2009). The availability of a mutant capable of 
catalyzing the reaction at pH 7 would allow the Gad-mediated production of 
GABA also at neutral pH. Further work will concern the stabilization of this 
and other mutants, since the enzyme tends to lose the cofactor during the 
catalysis. 
Finally, the preliminary structural study on E. coli apoGadB, started in this 
thesis work, has interesting implications in the open issue of PLP-dependent 
enzymes folding and in the possible involvement of proteins in the apo form 
in autoimmune diseases etiology. Supplementary work is required to 
optimize the experimental conditions and perform analytical and structural 
studies on an extra pure sample. 
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